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“I have a friend who's an artist and has sometimes taken a view which I don't agree with very well. 
He'll hold up a flower and say "look how beautiful it is," and I'll agree. Then he says "I as an artist can 
see how beautiful this is but you as a scientist takes this all apart and it becomes a dull thing," and I 
think that he's kind of nutty. First of all, the beauty that he sees is available to other people and to me 
too, I believe. Although I may not be quite as refined aesthetically as he is ... I can appreciate the 
beauty of a flower. At the same time, I see much more about the flower than he sees. I could imagine 
the cells in there, the complicated actions inside, which also have a beauty. I mean it's not just beauty 
at this dimension, at one centimeter; there's also beauty at smaller dimensions, the inner structure, also 
the processes. The fact that the colors in the flower evolved in order to attract insects to pollinate it is 
interesting; it means that insects can see the color. It adds a question: does this aesthetic sense also 
exist in the lower forms? Why is it aesthetic? All kinds of interesting questions which the science 
knowledge only adds to the excitement, the mystery and the awe of a flower. It only adds. I don't 
understand how it subtracts.”  














































































Standing at the end of my Ph.D. research work I feel good that I have the opportunity to express my 
gratitude to all people who have helped and inspired me during my doctoral study. 
 
First I want to thank my supervisors Dr. Carles Cantí Nicolàs and Dra.Rosa Maria Martí Laborda 
for their constant encouragement and guidance with an open mind during the entire period of my 
work. I consider myself to be extremely fortunate to obtain an opportunity to work under the guidance 
of Dr. Carles Cantí Nicolàs and have him as the mentor of my Ph.D. He was always generous to 
provide me intellectual space, and taught me the value of good scientific work. I would also like to 
express my sincere gratitude to Dra.Rosa Maria Marti for her continuous support during my Ph.D 
study and research. Her patience, motivation, enthusiasm, and immense knowledge had motivated all 
her advisees, including me. 
 
I wish to express my sincere appreciation to Dr. Xavier Matias Guiu for giving me an opportunity to 
be a member of IRB Lleida and a part of his group. Without his sound advice and constant selfless 
guidance the work presented in this thesis would not have been achieved. He was always there to 
guide me for every single step during the long four years of my Ph.D. 
 
I especially want to thank Dra.Judith Herreros for her support and patient advice throughout my 
thesis. Her perpetual energy and enthusiasm in research, deep vision, in depth knowledge and enormous 
experience in the field of cell biology, had helped and inspired  me a lot in my Ph.D study 
 
I wish to thank Dr. Joseph Esquerda and Dr. Olga Tarabal for their sound advices during the long 
sessions of calcium imaging. 
 
I am also grateful to Dr. Reinald Pamplona, Dra. Conchi Mora, Dr. Jose Valdivieso, Dra. Adriana 
Dusso, Dr. Xavier Dolcet, Dr. Mario Encinas, Dra. Judit Ribas, Dra. Andree Yeramian, Dra. Marta 
Llovera and Dr. Daniel Sanchis for their kindness and willingness to help each time they were asked.  
 
I would also like to show my gratitude to Dr. Ramon Vilella from the department of immunology, 
hospital clinic of Barcelona for providing me wide variety of melanoma cell lines.. 
 
I would like to thank UDL, Government of Catalunya and Government of Spain for giving me the 
financial support during my Ph.D. 
I am indebted to Dr. Nihar Ranjan Jana for giving me the opportunity to work for one year in 
National Brain research Centre, India. The associated experience broadened my perspective on the 
molecular biology techniques. I would like to thank late Dr. Swapan Kumar Das, Dr Aniruddha 
Mukherjee and Dr. Punarbasu Chowdhury for their continuous encouragement to do better science in 
my early university days. 
 
I also thank members of the neuronal differentiation and calcium signalling laboratory - Charumathi, 
Mireia (the most wonderful person) and Deepshikha for their collaboration, humour and 
encouragement. Thank you guys and keep up the good work!!! 
 
I would like to acknowledge my seniors Annabel, Nuria B and Milica for their immense support and 
assistance throughout all over my research work, publishing articles and preparation of thesis. 
  
I would like to thank Monica D, David, Esteban, Maya, Jiseng, Omar, Dani, Hugo, Nuria E, 
ChristinaG Laura, Christina M, Anna macia, Myriam, Marta, Junemei, Ester, Berta, Estella, Petya, 
Montse, Noelia, AnnaV, Dolors, Azahar, Carme G, Paolo, Hiren, Bupesh, Venkat, Saravanan for 
their help and encouragement.I would like to thank especially Carlos, Lilliana, Alejandra and Disha 
for being my friend and the support you gave me. I treasure all precious moments we shared with you 
people in the Institute, hospital as well as in the caferetia!!!! It is a pleasure working with you people. 
  
I am grateful to Dra.Anis Panosa for her enormous help to obtain best results and best quality images 
of flow cytometry studies. 
 
I express full-hearted gratitude to my parents. Without their blessings and mental support, it would 
not be possible for me to cross the long way of Ph.D. To them I dedicate my thesis. No words are 
sufficient to express my heartfelt thanks to my sister, my brother in law and little Uttiyo for their 
encouragement and support especially during the tough times in my career. My deepest gratitude also 
goes to my parent in laws for their belief in me and whole hearted motivation for last couple of years. 
                         
Finally I thank my wonderful and patient wife Upasana for always standing by me, supporting and 
encouraging me to reach my fullest potential and always reassuring me that there is light at the end of 
the tunnel. 
 




















































1 Melanoma 13 
1.1 Introduction 13 
1.2 Melanoma epidemiology 15 
1.3 Melanoma and calcium signalling 15 
2 Voltage Gated Calcium Channel 16 
2.1 Introduction 16 
2.2 Primary Structure and Properties of Ca
2+
 Channel α1 Subunits 16 
3 Involvement of voltage-gated Ca
2+
 channels in the control of cellular 
proliferation 
20 
4 Voltage gated calcium channel and cancer 21 
4.1 L-type calcium channel and cancer 21 
4.2 T type calcium channel and cancer 22 
4.3 PQ/R type calcium channel and cancer 22 
5 Effect of calcium channel blockers on cellular proliferation 24 
5.1 Effect of T type calcium channel blockers on cellular proliferation 24 
5.2 Effect of L type calcium channel blockers on cellular proliferation 26 
6 Calcium signalling and cell death 26 
7 Endoplasmic reticulum stress 28 
8 Autophagy 31 
9 Role of Autophagy in cancer 34 
9.1  Autophagy in melanoma progression 35 










 Reagents and culture materials 43 
 Sequence of short interfering RNA 44 











1. Cell culture 49 
1.1 Trypsinization of adherent cells 49 
1.2 Freezing and thawing cultured cells 50 
2. Cell viability assays 50 
3. Calcium imaging 51 
3.1 Recording solution 52 
4. Polymerase Chain Reaction (PCR) 52 
4.1 Isolation of RNA and cDNA synthesise 52 
4.2 Semi-quantitative PCR 53 
4.3 XBP-1 splicing assay 53 
4.4 Quantitative PCR (Real Time PCR) 54 
5. Propidium iodide (PI) staining and flow cytometry 55 
6. 5-Bromodeoxyuridine incorporation 55 
7. Western blot analysis 55 
8. Gene knockdown by siRNA 56 
9. LysoTracker
®
 Red DND-99 staining 56 
10. Hoestch 33258 staining 57 
11. Statistical analysis 57 
  




 Chapter 1:  




1. Expression of VGCCs in control normal melanocytes and melanoma 63 
cell 
1.1 L-type channels  63 
1.2 N-type, P-Q-type and R-type channels 63 
1.3 T-type channels  66 
2. Moderate hypoxia induces the selective up-regulation of T-type and 
L-type Channels  
66 





 quenching at the FURA-2 isosbestic 
point 
72 
5. Role for T-type channels in melanoma cell cycle progression 72 
6. Cell proliferation in hypoxia 74 




 Chapter 2: 
T-Type calcium channel blockers and gene silencing induce 
endoplasmic reticulum stress and inhibit constitutive autophagy 
in human cutaneous melanoma-derived cell lines. 
 
79 
1. Effect of Mibefradil and Pimozide on cellular viability 81 
2. Mibefradil induces cell cycle arrest and a reduction in proliferation 
rate 
81 
3. Mibefradil and Pimozide trigger apoptosis  83 
4. T-type calcium channel blockers and RNAi-mediated gene silencing 
of Cav3.1 and Cav3.2 channels induce endoplasmic reticulum stress 
87 
5. Melanoma cells display a basal autophagy which is inhibited by T-






1. Expression of L type channels 101 
2. Expression of N type, P-Q type, R type channels 101 
3. Expression of T type channels 102 
4. Dual effect of T-type channel pharmacological blockers on 
melanoma cells viability: decreased cell proliferation and increased 
apoptosis 
103 
5. T-type calcium channel blockers induce ER stress and non-adaptive 
UPR in melanoma cells 
104 
6. The knockdown of Cav3.1 and Cav3.2 channels mimics the effects of 
T-type channel pharmacological blockade   
106 
7. T-type calcium channels blockade or gene silencing inhibits the 















   
   
   
   
   
   
   
   
   
   



































































































































AIF Apoptosis-inducing factor 
DNA Deoxyribonucleic acid 
VGCC Voltage gated calcium channel 
RNA Ribonucleic acid 
JNK Jun N-terminal kinases 
siRNA   Small interfering RNA 
VDAC Voltage dependent anion channel 
Cav Voltage gated calcium channel 
DMSO Dimethyl sulfoxide 
dNTP Deoxyribonucleotide 
ER Endoplasmic reticulum 
FBS Foetal bovine serum 
mRNA Messenger RNA 
Q RT-PCR Quantitative Real Time Polymerase Chain reaction 
RT-PCR Reverse Transcriptase Polymerase Chain Reaction 
WB  Western Blott 
XBP-1 X Box Binding Protein1 
GADD153 Growth Arrest And DNA Damage Inducible Gene 153 
GRP 78 Glucose Regulated Protein 78 
ATG Autophagy related gene 
Bcl-2 B-cell lymphoma 2 
ATF Activating transcription factor  
BiP Binding immunoglobulin protein 
nM Nano molar 
eIF2α Eukaryotic initiation factor 2α 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
LC3 Light Chain 3 
IRE1α Inositol-requiring enzyme α 
PERK Protein kinase RNA-like endoplasmic reticulum kinase 





FURA2/AM Fura-2-acetoxymethyl ester 
Ca
2+
 Calcium ion 
IP3 Inositol 1,4,5-trisphosphate 
Kda Kilo Dalton 
kb Kilobase 







TBST-buffer Tris Buffer saline in Tween 20 
VOCC Voltage operated Calcium channel 
SERCA Sarco / endoplasmic reticulum Ca
2+
- ATPase 
SOCC Store operated calcium channel 
AV Autophagic Vacuole 
eIF3e Eukaryotic translation initiation factor 3, subunit e 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
PBS Phosphate buffer saline 
WST-1 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene 
disulfonate 
cAMP Cyclic adenosine monophosphate 
CaMK Calcium/Calmodulin-dependent protein kinase  
shRNA Small hairpin RNA 
XBP-1 X Box Binding Protein 
SDS Sodium dodecyl sulphate 
Sec. Seconds 
HRP Horseradish peroxidase 
Tween 20 Polyoxyethylene sorbitan monolaurate 
Caspases Cysteine-containing aspartate specific proteases 
CQ Chloroquine 
BAX  BCL-2 associated X protein 
PTEN Phosphatase And Tensin Homologue Deleted On Chromosome 10 
PI3K Phosphatidylinositol-3-kinase 
PCD Programmed Cell Death 
PTP Permeability transition pore 
PI Propidium Iodide 
RGP Radial Growth Phase 
VGP Vertical growth phase 
SSM Superficial spreading melanoma 
UV Ultraviolet 
PKC Protein kinase C 
PDGF Platelet-derived growth factor 
VEGF Vascular endothelial growth factor 
CDK Cyclin dependent kinase 
cDNA Complementary deoxyribonucleic acid 
dNTP Deoxynucleotide triphosphate  
ERSE ER stress response element  
UPRE UPR promoter element  
ERAD ER-associated degradation  


















































































The expression of voltage-gated calcium channels (VGCCs) has not been reported 
previously in melanoma cells in spite of increasing evidence of a role of VGCCs in 
tumorigenesis and tumour progression. To address this issue we have performed an 
extensive RT-PCR analysis of VGCC expression in human melanocytes and a range of 
melanoma cell lines and biopsies. In addition, we have tested the functional expression of 
these channels using Ca
2+
 imaging techniques, and examined their relevance for the 
viability and proliferation of the melanoma cells. Our results show that control 
melanocytes and melanoma cells express channel isoforms belonging to the Cav1 and 
Cav2 gene families. Importantly, the expression of isoforms of low voltage-activated Cav3 
(T-type) channel is restricted to melanoma. We have confirmed the function of T-type 
channels as mediators of constitutive divalent cations influx in melanoma cells. 
Additionally, pharmacological and gene silencing approaches demonstrate a role for T-
type channels in melanoma viability and proliferation.  
 
These results encourage the analysis of T-type VGCCs as targets for therapeutic 
intervention in melanoma tumorigenesis and ⁄or tumour progression. In this regard, we 
have found that Mibefradil and Pimozide, two structurally-unrelated, clinically-used T-
type Ca
2+
 channel blockers, inhibit the growth of melanoma cells in vitro, and that this 
effect is due to both a reduction in the proliferation rate and an induction of caspase-
dependent cell death. We have further explored the molecular pathways leading to T-type 
channels blockers-mediated apoptosis, and found that both drugs induce endoplasmic 
reticulum (ER) stress and a subsequent inhibition of the basal autophagy present in 
melanoma cells. Finally, we have demonstrated by gene silencing experiments that the 
Cav3.1 and Cav3.2 isoforms of T-type channels are the targets of T-type channel blockers, 
regarding their effects on melanoma ER-stress and autophagy.  
 
Altogether, the results attained in this thesis point to T-type Ca
2+
 channels as putative 











En aquest treball de tesi hem estudiat per primera vegada l’expressió funcional dels 
canals de calci dependents de voltatge (CCDV) en melanòcits humans i un ampli rang de 
línies cel.lulars i biòpsies de melanoma humà, mitjançant tècniques de biologia molecular 
i d’imatge. Els nostres resultats demostren que els melanòcits control i les cèl.lules de 
melanoma expréssen isoformes de les famílies de gens Cav1 i Cav2. De forma destacable, 
l’expressió d’isoformes de la família Cav3 (canals de tipus T) es troba restringida a les 
cèl.lules de melanoma, en les que promouen la progressió del cicle cel.lular. 
 
Aquests resultats motiven l’anàlisi dels CCDV-T com a dianes terapèutiques contra la 
tumorigènesi i/o progressió tumoral del melanoma. En aquesta línea, hem trobat que 
mibefradil i pimozida, dos bloquejants de CCDV-T d’us clínic, inhibeixen el creixement 
de les cèl.lules de melanoma in vitro, i que aquest efecte és degut tant a una reducció de la 
proliferació cel.lular, com a una inducció de la mort dependent de caspases. Hem explorat 
les vies moleculars implicades en el procés apoptòtic i hem trobat que ambdues drogues 
indueixen estrés de reticle endoplasmàtic (RE) i la inhibició subsequent de l’autofàgia 
basal constitutiva present a les cèl.lules de melanoma. Finalment, hem demostrat, a través 
del seu silenciament gènic, que la isoforma Cav3.2 és la diana molecular dels bloquejants 
de CCDV-T, en el que respecta als seus efectes sobre l’estrés de RE i l’autofàgia. 
 
Conjuntament, els resultats obtinguts en el decurs d’aquesta tesi apunten als canals de 
tipus T como a possibles marcadors de pronòstic i/o dianes terapèutiques contra la 


















Hemos estudiado por primera vez la expresión funcional de los canales de calcio voltaje-
dependientes (CCDV) en melanocitos humanos y un amplio rango de líneas celulares y 
biopsias de melanoma humano, mediante técnicas de biología molecular y de imagen. 
Nuestros resultados demuestran que los melanocitos control y las células de melanoma 
expresan isoformas pertenecientes a las famílias de genes Cav1 y Cav2. De forma 
destacable, la expresión de isoformas de la família Cav3 (canales de tipo T) se encuentra 
restringida a las células de melanoma, en las que promueven la progresión del ciclo 
celular. 
 
Estos resultados motivan el análisis de los CCDV-T como dianas terapéuticas contra la 
tumorigénesis y/o progresión tumoral del melanoma. En esta línea, hemos encontrado que 
mibefradil y pimozida, dos bloqueantes de CCDV-T de uso clínico, inhiben el 
crecimiento de las células de melanoma in vitro, y que este efecto es debido tanto a una 
reducción de la proliferación celular como a una inducción de la muerte dependiente de 
caspasas. Hemos explorado las vías moleculares implicadas en el proceso apoptótico y 
hemos hallado que ambas drogas inducen estrés de retículo endoplasmático (RE) y la 
inhibición subsiguiente de la autofagia basal constitutiva presente en las células de 
melanoma. Finalmente, hemos demostrado, a través de su silenciamiento génico, que la 
isoforma Cav3.2 es la diana molecular de los bloqueantes de CCDV-T en lo concerniente 
a sus efectos sobre el estrés de retículo endoplasmático y la autofagia. 
 
Conjuntamente, los resultados obtenidos en el curso de esta tesis apuntan a los canales de 
tipo T como posibles marcadores de pronóstico y/o dianas terapéuticas contra la 






























































































Malignant melanoma is a neoplasm of the skin which arises primarily from transformed 
melanocytes de novo or from dysplastic, congenital, or common nevi
1-5
. As in many 
cancers, both genetic predisposition and exposure to environmental agents are risk factors 
for melanoma development. Researchers have identified a number of risk factors 
associated with melanoma. These risk factors are grouped into four categories: 1. 
Environmental. 2. Genetic. 3. Immunosuppresive. 4. Previous melanoma. Studies have 
shown that melanoma primarily affects fair-haired and fair-skinned individuals and those 
who burn easily or have a history of severe sunburn. The UV component of sunlight 
causes skin damage and increases the risk for skin cancers such as melanoma. The exact 
mechanism and wavelengths of UV light that are the most critical remain controversial, 





Cutaneous melanoma can be subdivided into several subtypes, primarily based on 
anatomic location and patterns of growth. The majority of melanoma subtypes are 
observed to progress through distinct histological phases. As cutaneous melanomas 
progress from the radial growth phase (RGP) to the vertical growth phase (VGP), 
treatment options, cure rates, and survival rates decrease dramatically. Most melanoma 
subtypes demonstrate a slow RGP restricted to the epidermis, followed by a potentially 
more rapid VGP. RGP melanoma cells extend upward into the epidermis (pagetoid 





Although cutaneous melanoma only accounts for 5-7% of all skin malignancies, it is the 
most lethal, being responsible for about 75% of all skin tumour deaths
7, 11
. Once in 
advanced stage, the prognosis of patients with melanoma becomes very poor. 





lesions may present various clinical subtypes, and within these may display wide 
diversity in characteristics of form and clinical progression. Such heterogeneity can make 









. Furthermore, recent cellular and molecular studies are continuing to reveal 
many additional variations, suggesting that such heterogeneity in melanoma may underlie 






Figure 1. Various stages of melanomagenesis and tumor progression for melanomas arising on a 
melanocytic nevi. a. Normal skin. This shows an even distribution of melanocytes within the basal 
layer of the epidermis. b. Naevus. In the early stages, benign melanocytic naevi occur with 
increased numbers of melanocytes. c. Radial-growth-phase (RGP) melanoma. This is considered 
to be the primary malignant stage. d. Vertical-growth-phase (VGP) melanoma. This is the first 
stage that is considered to have malignant potential and leads directly to metastatic malignant 
melanoma by infiltration of the vascular and lymphatic systems. Pagetoid spread describes the 
upward migration or vertical stacking of melanocytes that is a histological characteristic of 









1.2 Melanoma epidemiology 
 
Rising incidence rates of cutaneous melanoma have been observed during the last four 
decades in white populations worldwide. The cancer statistics in the United States have 
revealed 6 cases per 100,000 inhabitants and year at the beginning of the 1970s and 18 
cases per 100,000 inhabitants and year at the beginning of 2000, demonstrating a three-
fold increase in incidence rates. Incidence rates in central Europe increased in the same 
time period from 3 to 4 cases to 10 to 15 cases per 100,000 inhabitants and year, which is 
very similar to the increase in the United States. Cohort studies from several countries 
indicate that the trend of increasing incidence rates will continue in the future for at least 
the next 2 decades; thus, an additional doubling of incidence rates is expected. The 
highest incidence rates have been reported from Australia and New Zealand, from 40 to 








-signaling of human cutaneous melanoma is in the focus of intensive research in 
recent years. Genomic and functional studies pointed to the important role of various Ca
2+
 
channels in melanoma, but these data were contradictory. Ca
2+
-signaling is suspected to 
play an important role in the development as well as in the viability and motility of 
melanoma cells
18-20
. The significance of Ca
2+
 in melanoma is supported by the fact that a 
Ca
2+
-dependent isoform of protein kinase C is overexpressed in melanoma
21
. On the other 
hand, it is known that intracellular Ca
2+
 oscillations are critical for the survival and 
migration of melanoma cells
18, 19
. The melanocytic linage is characterized by a special 
resistance to apoptosis, which might be attenuated during malignant transformation. It is 
now well established that apoptosis regulatory proteins B-cell lymphoma/leukemia-2 
gene/Bax are regulators of the endoplasmic reticulum Ca
2+
 stores, and that Ca
2+
 is a key 
mediator of apoptosis in a variety of cell types
22
. It has been claimed that the enhanced 
expression and/or function of Ca
2+
 channels in the plasma membrane of human melanoma 



















) is a ubiquitous second messenger, and temporally and spatially 
coded changes in the cytosolic Ca
2+
 levels are critical for linking external stimuli to cell 
physiology. Ca
2+
-signaling directs a wide range of intracellular processes, ranging from 
short-term control of contraction, synaptic transmission, endo and exocytosis and 
modulation of enzyme function and metabolism, to longer-term control of gene 
expression, cell cycle progression, apoptosis, differentiation and proliferation
24-26
. The 
extracellular milieu is the ultimate source of Ca
2+
, which flows into the cells through ion 
channels present in plasma membrane (figure 2).              
 
Figure 2. Regulation and distribution of intracellular concentration of free Ca
2+
. The 
increase in intracellular concentration of free Ca
2+
 can be triggered by the release of 
Ca
2+ 
from intracellular stores, especially the endoplasmic reticulum, and by influx from 
the extracellular space through voltage-dependent Ca
2+
 channels and Ca
2+
-permeable 





2.2 Primary Structure and Properties of Ca
2+
 Channel 1 Subunits 
VGCCs were initially isolated as large heteromeric proteins from the skeletal muscle Ca
2+
 
channel complex. The so-called DHP receptor complex contains 5 protein subunits, 
which were termed α1 (170 kDa), α2 (150 kDa), β (52 kDa), δ (17–25 kDa) and γ (32 
kDa)
28, 29
. Up to 10 genes have been described to encode the pore-forming α1 subunit of 
VGCCs, being the most highly selective ion channels for Ca
2+








Figure 3. α1 subunit of voltage-gated Ca
2+
 channels showing 4 homologous repeated domains (I-
IV) with intracellular linkers, and N and C terminus. Each of the 4 homologous repeated domains 
is comprised of 6 membrane-spanning segments (S1-S6). The inward loop between the S5 and S6 
transmembrane segments lines the pore, while the S4 transmembrane segment contains positively 




) that move outwardly upon membrane depolarization, causing 
channel opening. 
The α1 subunit is a large protein with 24 transmembrane segments arranged in 4 
homologous repeated domains, with intracellular linkers and N and C terminus. The N 
and C-terminus exert important modulatory functions on the expression and function of 
the channels. Each of the 4 domains is comprised of 6 putative membrane-spanning 
segments (S1-S6). The inward dipping loop between S5 and S6 transmembrane segments 
form the channel pore, while the S4 transmembrane segments contain positively charged 
amino acids and act as voltage sensors, moving outwardly upon membrane depolarization 
and rendering the calcium channel open by an allosteric mechanism
28,29 
(Figure 3). On the 
basis of sequence homology and functional properties, VGCCs are classified in two major 
groups: high voltage-activated calcium channels (HVAs), which activate at depolarized 
membrane potentials (usually - 40 mV or more positive), and low voltage-activated 
calcium channels (LVA or T-type) which open at more negative membrane potentials, 
closer to the typical cell resting membrane potentials (between -80 and -60 mV). HVA 
calcium channels include L-type, R-type, N-type and P/Q-type calcium channels. LVA 
calcium channels include the T-type calcium channels
30
 (Figure 4). Some of the key 
features of high and low voltage-activated Ca
2+ 
channels are displayed in Table 1, and 








Figure 4. Dendrogram showing the classification of VGCCs on the basis of their sequence 
homology and functional properties (scheme modified from Eric A.Ertel 2000)
31
 




Molecular nomenclature Main localization 







Cav1.1 skeletal muscle 
α1C Cav1.2 smooth and cardiac muscle, CNS 
α1D Cav1.3 Sinoatrial node, cochlear hair 
cells, neuronal (dendritic) 











α1B  Cav2.2 Throughout the brain and 
peripheral nervous system. 
R-type calcium 
channel ("Residual") 
α1E  Cav2.3 CNS; cell bodies,  some distal 













α1G  Cav3.1 Neuronal, cardiac 
 
α1H Cav3.2 Neuronal and many other tissues 
α1I Cav3.3 Neuronal 
 
 
     Table 2.  Ca
2+
 channel antagonists and agonists (L, T, P/Q, N, R type) 
 
 
            Type           Activator              Inhibitor 









L-type BAY-K 8644(60,133) Dihydropyridines 
(Nimodipine, Nifedipine, 
nitrendipine amlodipine, 
nicardipine Nifedipine , 





P/Q-type NA ω-Agatoxin IVA (peptide) 
N-type NA ω-CgTx GVIA (peptide) 







3. Involvement of voltage-gated Ca
2+
 channels in the control of cellular proliferation 
Numerous studies have demonstrated that the Ca
2+
 influx through VGCCs, especially 
from the Cav1 (L-type) family, results in signalling that affects the expression of genes 




Dolmetsch et al (2001) showed that an isoleucine-glutamine motif in the carboxyl 





in turn activates the Ras/mitogen activated protein kinase pathway and conveys the Ca
2+
 
signal to the nucleus, stimulating the expression of genes essential for neuronal survival
37 
In the nucleus, Ca
2+
 has been also involved in DNA replication through its role activating 
CaM-kinase II and IV, phosphatase like calcineurin, and regulating nuclear factors such 
as Ca
2+







 seems to be particularly important for specific phases of the cell cycle; for example, 
the transition from the G1/S interphase (initiation of DNA synthesis) and the G2/M 
interphase (initiation of mitosis), is dependent upon CaM-kinase II
38
. In proliferating 
cells, these Ca
2+
 signals often form oscillatory patterns involving entry of external Ca
2+
 
and release of Ca
2+
 from internal stores
39
; these oscillations play an important role in the 
ability of cells to reenter the cell cycle and initiate DNA synthesis at the G1/S phase 
transition, and for the initiation of mitosis during the M phase of the cell cycle; T-type 
Ca
2+
 channels are particular well suited to participate in such oscillations due to their 
unique biophysical properties, among them the ability to open with relatively small 
depolarizations, the rapid kinetics of inactivation and the overlapping of steady-state 
activation and inactivation curves
28
.In fact, cells in the proliferative phase (G2/M) have 
been frequently reported to express T-type Ca
2+
 channels, whereas the same cells in the 




. That way, 
in vascular smooth muscle cells the percent of total Ca
2+
 channel current for T-type Ca
2+
 
channels was 37% in the G1 phase and increased to 90% in the S and beginning of the M 
phases
42
. In human pulmonary artery myocytes, the gene silencing of 1G subunits of T-
type Ca
2+
 channels inhibited proliferation and resulted in an increased number of cells in 
the G0/G1 (non-proliferative) cell cycle stage
43, 44
. Furthermore, Western blot analysis at 







channels is associated with the G2/M phase of the cell cycle
40-45
. Taken together, these 
data strongly suggest that T-type Ca
2+
 channels play an important role in Ca
2+
-signaling 
associated with S phase-related events, when DNA synthesis is increased in preparation 










-dependent signalling is frequently deregulated in cancer cells and, importantly, 
VGCCs may play a role in remodelling calcium homeostasis. The following sub-sections 
summarize the knowledge achieved for the different VGCC types up to date. 
4.1 L-type Ca
2+
 channels and cancer 
The expression of L-type Ca
2+
 channels in non-excitable cells is limited and, even if these 
channels are present, they require membrane depolarization to become activated. It has 
been shown that the cell membrane may be depolarized by the action of certain mitogens, 





through L-type channels has been implicated in the pro-proliferative action of endothelin-
1 (ET-1) in the SPC-A1 human lung adenocarcinoma cell line
47-49
. In some cases, the 
cells have been shown to express a splice variant of L-type channels lacking voltage-





. There are pharmacological evidences for VGCC-
mediated Ca
2+
 influx in colonic cell lines
54-56
 and, interestingly, the up-regulation of the 
Cav1.2 L-type channel isoform has also been reported in colon cancer
57
. In a similar line, 
it has been suggested that the progression of colon cancer is often associated with 
enhanced mitogenic signals such as epidermal growth factor (EGF) and EGF receptors
58, 
59
 and their downstream signaling kinase c-src
60
, which in turn increases the activity of L-
type channels
61
. The up-regulation of Cav1.1 in colorectal carcinoma cell lines and 
biopsies has also been described
64 
(table 3). Other works have unveiled uncommon 
coupling mechanisms of L-type channels to either cell survival or oncogenicity. For 
instance, Green et al. reported that a population of endosomes whose rapid trafficking is 
controlled by Ca
2+
, contains Cav1.2 channels in their membranes; they further identified a 
protein domain in the II-III loop of Cav1.2 channels that binds Eukaryotic translation 







internalization and endosome trafficking; this finding provides an interesting link between 




4.2 T-type calcium channel and cancer 
The Cav3.1 isoform of T-type voltage gated calcium channels has been reported to be 
overexpressed in glioma cells
67, 43
. The knock down of Cav3.1 in esophageal carcinoma 
cells can reduce cell proliferation via the p53 tumor-suppressing transcription factor-
dependent pathway, leading to the up-regulation of the cell-cycle arrest protein p21
68
. The 
Cav3.2 isoform was reported to be over-expressed during neuroendocrine differentiation 
of prostate cancer cells
69
. Interestingly, a decreased function of T-channels also may play 
a role in cancer development and progression, as transformation of fibroblasts by ras 
oncogene reduces T-currents
70-72
. Hypermethylation of the CACNA1G gene in various 
human tumors (colon, colorectal, pancreatic and gastric cancers, as well as in acute 
myelogenous leukemias) results in silencing of Cav3.1 channels, indicating that 
CACNA1G may be a putative tumor suppressor gene
73-75 
. Expressions of isoforms of T 
type calcium channel in various types of cancer are described in table 4. 
4.3 P/Q, R-type calcium channels and cancer 
P/Q and R-type VGCCs are involved in neuronal plasticity and survival, and mediate fast 
neurotransmission in the central and peripheral nervous systems. There are few evidences 
suggestive of a role of P/Q-type or R-type Ca
2+
 channels in cancer development. 
Nonetheless, the activity of Cav2.3 channels has been reported to promote chromogranin 
A secretion from neuroendocrine tumor cells
93
. It has also been shown that the enhanced 
proliferation of a tumorigenic mouse ovarian epithelial cell line by follicle stimulating 





Finally, several studies have reported that Cav2.1 antibodies play a pathogenic 












Table 3. L-type calcium channels and cancer 
Cell type L type isoform  Reference 
Colon carcinoma Cav1.2 57 
Colorectal carcinoma Cav1.1 64 
lung adenocarcinoma undefined 47-49 
Human B lymphoma cells Cav1.2 65 
Human jurkat t cells Cav1.4, Cav1.1 66,50 
Table 4. T-type calcium channels and cancer  
Cell type T type isoform  Reference 
breast carcinoma Cav3.1, Cav 3.2 75-77,67 
neuroblastoma Cav3.1, Cav3.2 67,78-80,77,43 
retinoblastoma Cav3.1,Cav3.2, Cav3.3 81,82 
glioma Cav3.1, Cav3.2 67,43 
Prostate carcinoma Cav3.1, Cav3.2 69,83,75,77 
Esophageal carcinoma Cav3.1, Cav3.2, Cav3.3. 68 
fibrosarcoma Cav3.1 84 
Colorectal carcinoma Cav3.1 75 
pheochromocytoma Cav3.1, Cav3.2 85,86 
adrenocarcinoma Cav3.2 87 
insulinoma Cav3.1 88 
Thyroid carcinoma Cav3.2 89 
Colon carcinoma Cav3.1 75,90 
Pancreatic carcinoma Cav3.1 73 
Hepatocellular carcinoma  Cav3.1, Cav3.2,Cav3.3 74 
Gastric carcinoma Cav3.1 75 
Acute myelogenous leukemias Cav3.1 75 








5. Effects of calcium channel blockers on cellular proliferation 
 
In line with the relevance of the different VGCC families in cell proliferation summarized 
in the preceding sections (and with our own results attained during the development of 
this Thesis), only the blockade of L-type and T-type Ca
2+
 channels has shown to have an 
impact on cancer cell growth. L-type and T-type Ca
2+
 channel blocking agents are 
classified into broad groups according to their chemical structure like benzodiazepines, 
diphenylbutyl piperidines, phenylalkyl amines, piperazine derivatives and dihydro 
pyridines (Figure 2).  
 
Although the main actions of the L-type and T-type channel blockers concern the 
cardiovascular system and include dilatation of coronary and peripheral arterial 
vasculature, reduction of heart rate and slowing of AV conduction, many articles have 
suggested antiproliferative effect of these drugs in vivo and in vitro. This relevant aspect 
is discussed in the following section. 
 
5.1 Effect of T-type calcium channel blockers on cellular proliferation 
 
 There are a variety of agents that can affect T-type calcium current with varying degrees 
of specificity. Kurtoxin is a peptide purified from the Parabuthus transvaalicus scorpion 
venom and stands out like the most specific blocker of T-type channels available to date
97, 
98
. Kurtoxin binds Cav3.1 and Cav3.2 T-type channels with high affinity (low nanomolar) 
and inhibits the T-type calcium currents by modifying the channel gating
98
. The 
antiproliferative properties of Kurtoxin have been documented in vitro in the rat ductus 




Mibefradil, a benzimidazolyl-substituted tetraline derivative, is distinguished from other 
calcium channel antagonists because it preferentially blocks low-voltage-activated T-type 
calcium channels (T-channels) with 10 to 20 times more selectivity than high-voltage-




. Mibefradil was introduced clinically in 
1997 as an antianginal and antihypertensive agent, but was withdrawn from the market 
less than a year after its release due to potentially life-threatening interactions with β-




However, Mibefradil has been reintroduced in the 







glioblastoma multiforme and ovarian cancer from the American Food and Drug 




Mibefradil has been recognized as an effective inhibitor 














 and breast cancer
82
 cell lines. Apart from its anti-proliferative properties, 
Mibefradil has been shown to suppress Ca
2+ 
mediated spikes, waves, cell motility and 
invasive properties of HT1080 fibrosarcoma
84
. Anticancer effects of Mibefradil has also 
been investigated on tumor cells in vivo. Taylor et al. reported that the local injection of 
Mibefradil induces the death of human breast carcinoma cells implanted into 




The antipsychotic drug Pimozide has also been shown to be a potent inhibitor of T-type 
and L-type Ca
2+
 channels, but with less selectivity than Mibefradil
108
. In pituitary and 




whereas in adrenal glomerulosa 
and spermatogenic cells, Pimozide prevented Ca
2+












In the latter, the apparent mechanism of action was through 
inhibition of CaM activity
112
. Pimozide had also been introduced in the clinical trial of 
patients suffering from melanoma, although its beneficial effects were attributed to the 




Using the structure-activity relationship of known T-type channel blockers, Gray et. al. 
synthesized two new inhibitors of Ca
2+
 entry, TH-1177 and TH-1211. These two 
compounds blocked T-type channels and capacitative Ca
2+
 entry and decreased the 
proliferation rate of breast and prostate cancer cell lines with a similar efficacy to that of 
Mibefradil
77
. Similarly, McCalmont et al. described the synthesis of several novel T- type 
channel antagonists that inhibited Ca
2+







, arachidonic acid metabolites including 
anandamide
106, 117
 and nordihydroguariatetic acid
118
, can also modulate T-type Ca
2+
 











5.2 Effect of L-type calcium channel blockers on proliferation 
 
It has been shown that dihydropyridine derivatives such as Nimodipine, Nifedipine, and 
amlodipine inhibit the proliferation and DNA synthesis of epidermoid carcinoma cells 
119-
122,161
. Verapamil, Nifedipine and Diltiazem have also been reported to inhibit the growth 
of human brain tumor cells in vitro
112, 123
. Interestingly, L-type channel blockers have also 
displayed tumor inhibition capabilities in vivo: verapamil and Diltiazem inhibited the 




oral administration of 
amlodipine, Diltiazem or verapamil were demonstrated to inhibit the proliferation of 
human breast cancer cell in the athymic mouse, without any effect on mouse body weight 




6. Calcium signalling and cell death 
 
Proliferation and apoptosis are two key processes determining normal tissue homeostasis. 
Apoptosis is a genetically determined self-destruction process that is characterized by 
membrane blebbing, DNA fragmentation and formation of apoptotic bodies
125
. Two 
major intracellular apoptosis pathways are the death receptor-mediated (extrinsic) 




Central to these apoptotic 
processes are a group of caspases (a family of cysteine proteases) that rapidly demolish 
cellular structures and organelles in an orderly manner. Apoptotic Caspases include 
‘initiator Caspases’ (Caspase 2, 8, 9 and 10) that start the apoptotic Caspase cascade, and 
‘effector Caspases’ (Caspase 3, 6 and 7) that disassemble the cell 
127
. De-regulated cell 
proliferation together with the suppression of apoptosis provides the condition for 
abnormal tissue growth, which ultimately can turn into the uncontrolled expansion and 
invasion characteristic of cancer. Although in molecular terms proliferation and apoptosis 
seem to be clearly delineated, both of them involve intense Ca
2+
 signaling and a 
remodelled Ca
2+





-dependent apoptotic mechanisms can be subdivided roughly into mitochondrial, 
cytoplasmic and endoplasmic reticulum mediated. 
 
Mitochondria represent a central integration point for the signals regulating cells destiny. 
Ca
2+












primary causes for mitochondrial permeability transition, which is at least partly mediated 
by the opening of permeability transition pore (PTP), a multi-protein complex located at 
the contact sites between the inner and the outer mitochondrial membranes. PTP opening 
permits releasing of mitochondrial apoptogenic factors, such as cytochrome c (Cyt-c) and 
apoptosis-inducing factor (AIF) into the cytoplasm where they in turn activate death-
executing caspase cascade. 
 
An initial cytosolic Ca
2+
 overload may also trigger apoptosis without directly involving 
Ca
2+
-mediated mitochondrial permeability transition. It mainly relies on the activation of 
a Ca
2+
-CaM-dependent phosphatase, namely calcineurin. Calcineurin-catalyzed 
dephosphorylation promotes apoptosis by regulating the activity of a number of 
downstream targets including pro-apoptotic Bcl-2 family member, Bad
122
 and 





also some other Ca
2+
-dependent enzymes, which take part in the apoptotic events, among 


















 is pumped into the ER by SERCA adenosine 
triphosphatases (ATPases) and is released by inositol 1,4,5-trisphosphate (IP3) or 






A significant fraction of the released 
Ca
2+







This close connection allows mitochondria to modulate, propagate, and 
synchronize Ca
2+
 signals and to prevent ER depletion by recycling Ca
2+
 to the ER. The 
ER-mitochondria connection enables Ca
2+
 signals not only to fine tune cellular 
metabolism but also to modulate the ability of mitochondria to undergo apoptosis. The 
switch from a life to a death signal involves the coincidental detection of Ca
2+
 and pro-
apoptotic stimuli, and depends on the amplitude of the mitochondrial Ca
2+
 signal. The 
magnitude of mitochondrial Ca
2+
 signals, in turn, depends largely on the Ca
2+
 content of 
the ER, which is maintained by the balance between active Ca
2+
 pumping by SERCA and 
passive leakage through Ca
2+











7. Endoplasmic reticulum stress 
 




 ionophores that 
deplete Ca
2+
 levels from the ER lumen, inhibitors of glycosylation, chemical toxicants, 
oxidative stress or the accumulation of misfolded proteins in the ER, can all disrupt ER 
function resulting in “ER stress”. The ER responds by triggering specific signalling 
pathways, including unfolded protein response [UPR], the ER overload response [EOR], 
and the ER associated degradation [ERAD]. Overall activation of these pathways leads to 
a reduction in the amount of translocated proteins in ER lumen, augmentation of protein 
folding capacity of the ER, increased translocation and degradation of misfolded proteins 
in the ER. 
 
The UPR is initiated when the unfolded proteins exceed the capacity of ER-resident 
chaperone proteins, such as glucose-regulated proteins 78 and 94 (GRP78 and GRP 94), 
to bind them. The principal chaperone protein is GRP78, which normally binds the N 
terminal ends of three transmembrane proteins referred to as interferon inducible protein 
kinase regulated by RNA like ER kinase (PERK), inositol requiring enzyme 1 alpha 
(IRE1α) and activating transcription factor 6 (ATF6). When the capacity of the sensor 
protein GRP78 to bind the unfolded proteins is exceeded, the individual ER 
transmembrane proteins undergo homodimerization and autophosphorylation, which 




Figure 5.Under normal conditions, Ca
2+
 continuously cycles between the ER and mitochondria.  
Ca
2+
 is pumped into the ER by Ca
2+









enters mitochondria by a Ca
2+









PERK is a serine threonine kinase that has many targets. The kinase domain of activated 
phosphorylated PERK phosphorylates the alpha subunit of eukaryotic translation 
initiation factor 2 alpha (eIF2α), attenuating the initiation of translation and protein 
synthesis. PERK activation and eIF2α phosphorylation leads to: (a) a decrease in the 
protein folding capacity of the ER; (b) the induction of eIF2α phosphorylation- dependent 
ER stress genes; and (c) the promotion of cell survival. Phosphorylated eIF2α may also 
translate the transcription factor ATF4, that includes a target gene for a phosphatase 
growth arrest and DNA damage inducible gene 34 (GADD34) (which dephosphorylates 
eIF2α) and Growth Arrest and DNA damage inducible gene 153 (GADD153/CHOP). 
GADD153 is a member of CCAAT/enhancer binding proteins (C/EBPs). Generally 
expressed at low level in proliferating cells, GADD153 is strongly induced in response to 
stresses that result in growth arrest or cellular death including oxidative injury, genotoxic 
stress, anti cancer chemotherapy and ER stress. Recent studies suggest that 
overexpression of GADD153 plays a central role in the apoptotic process, including 
favouring the dephosphorylation of the proapoptotic protein Bad and the down-regulation 
of Bcl-2 expression. 
 
IRE1α acts both as a serine/threonine kinase and an endoribonuclease. The latter activity 
results in splicing of the mRNA for X box-binding protein 1 (XBP-1), a transcription 
factor that binds both the ER stress response element (ERSE) and the UPR promoter 
element (UPRE). The UPRE is associated with the expression of genes involved in the 
transport of unfolded proteins out of the ER and their degradation by the ubiquitin 
proteasome system, a process referred to as ER-associated degradation (ERAD). 
 
ATF6 shares many of the activities of IRE1. In response to ER stress, p90ATF6 
transits to the Golgi where it is cleaved by the proteases S1P and S2P, yielding a free 
cytoplasmic domain that is an active transcription factor, p50ATF6, which appears to be 
principally involved in induction of the chaperone proteins and to precede IRE1-
mediated production of the ERAD pathway. ATF4, ATF6 and XBP-1 are transcription 
factors that up-regulate ER chaperone proteins, folding enzymes and protein degradation 







their subsequent folding or in degradation of excessive misfolded proteins. Based on the 
current knowledge, the ATF6 and IRE1α-XBP1 pathways are generally regarded as anti-
apoptotic UPR, and they are found to be attenuated when ER stress is persistent, whereas 







Figure 6. Schematic outline of key aspects of endoplasmic reticulum stress and unfolded protein 




In mammals and, depending on the state of the cell and the type of ER stress encountered, 
the outcome can be an increase in the capacity of the ER folding machinery, a reduction 
of the amount of proteins entering the ER, an enhanced clearance of the proteins from the 
ER, apoptosis or autophagy. PERK, IRE1α and increased Ca
2+
 levels have been 












polyQ72 upregulates the expression of autophagic gene Atg12, and induces autophagy 
through the PERK-eIF2α signaling pathway
145
. In contrast Imaizumi and co-workers 







When cells are under stress, they may adopt survival strategies or may undergo a 
programmed cell death. Autophagy (self-eating) is a lysosomal pathway involved in the 
turnover of cellular macromolecules and organelles that is essential to maintain cell 
homeostasis in a “normal” environment. In addition, autophagy is an adaptive, inducible 
survival strategy that allows cells to cope with different kinds of stress. At least three 
different types of autophagy exist: microautophagy, chaperone-mediated autophagy 
(CMA) and macroautophagy. The main differences between them concern the way by 
which endocytosed cargo is delivered to lysosomes. (1) Microautophagy implies direct 
delivery through invagination and fission of lysosomal membrane, and not much is 
known about the molecular machinery involved in the process
148
.(2) CMA delivers 
certain proteins to lysosomes with the help of the cytosolic hsc70 chaperone, which 
recognizes a KFERQ-like motif in the target proteins
149
.(3) Macroautophagy, commonly 
regarded as “autophagy”, involves the envelopment of cytosol and/or organelles in the 
isolating membrane, which wraps around the cargo forming an autophagosome a vesicle 
surrounded by a double membrane. The autophagosome then undergoes a progressive 
maturation by fusion with endolysosomal vesicles creating an autolysosome, where the 
cargo is degraded (Figure 7). To date, more than 30 ATG (autophagy-related) genes 
required for autophagy and its related pathways have been identified in yeast and 
mammals. The Atg proteins required for autophagy are now classified into six functional 
groups: (1) the Atg1 kinase complex (Atg1-13-17-29-31), (2) Atg9, (3) the class III 
phosphatidylinositol (PI)3–kinase complex (Atg6 –Atg14–Vps15–Vps34), (4) the PI(3)P-
binding Atg2–Atg18 complex, (5) the Atg12 conjugation system (Atg12–Atg5–Atg16), 




In many cellular settings, the first regulatory process involves the de-repression of the 
mTOR Ser/Thr kinase, which inhibits autophagy by phosphorylating autophagy protein-







complex that contains Atg1 kinase and Atg17, and thus attenuates the Atg1 kinase 
activity. When mTOR is inhibited, re-association of dephosphorylated Atg13 with Atg1 
stimulates its catalytic activity and induces autophagy. Notably, the mammalian 
orthologue of the yeast Atg13 has not been identified to date.  
 
Initially vesicle nucleation and assembly of the primary autophagosomal membrane starts 
with activation of mammalian Vps34, a class III phosphatidylinositol 3 kinase (PI3K) to 
generate phosphatidylinositol-3-phosphate (PtdIns3P). Vps34 activation depends on the 
formation of a multi protein complex in which Beclin-1 (Becn1; the mammalian 
orthologue of Atg6), UVRAG (UV irradiation resistance-associated tumour suppressor 
gene) and a myristylated kinase (Vps15, or p150 in humans). The isolation membrane 
chooses its cargo and elongates until the edges fuse forming a double-membrane structure 
called an autophagosome. Two ubiquitin-like conjugation systems are part of the vesicle 
elongation process. One pathway involves the covalent conjugation of Atg12 to Atg5, 
with the help of Atg7 and Atg10. The second pathway involves the conjugation of 
phosphatidylethanolamine (PE) to LC3/Atg8 (LC3 is one of the mammalian homologues 
of Atg8) by the sequential action of the protease Atg4, Atg7 and Atg3. Lipid conjugation 
leads to the conversion of the soluble form of microtubule-associated protein 1 light chain 
3 (LC3; also know as Atg8 or LC3-I) to the autophagic vesicle-associated form (LC3-II). 
The mechanism of retrieval in which the Atg9 complex participates is poorly studied. The 
accumulation of LC3-II and its localization to vesicular structures are commonly used as 
markers of autophagy. Finally mature autophagosomes fuse with endosomes and 
lysosomes forming autolysosomes, where the final degradation of the cargo occurs.  
 
Cells lacking nutrients suppress mTORC1 activity via a pathway involving AMP-
activated protein kinase (AMPK), and activate the autophagy machinery that provides the 
starved cells with an alternative source of intracellular building blocks and energy, 
thereby enhancing the cell survival during the stress. Although as indicated above 
autophagy is a homeostatic mechanism, notably it does not always promote cell survival; 
under some circumstances autophagy can mediate non-apoptotic cell death or type II 
programmed cell death (PCD II),  which is generally caspase-independent and 











                                      
Figure 7. Schematic depiction of macroautophagy in mammals (scheme taken from M. 






-signalling regulates autophagy, but the exact mechanisms involved are 
still under debate. Removal of Ca
2+ 
by chelation blocks autophagy at an early stage prior 
to LC3 conversion and autophagosome formation156. Ca
2+ 
has previously been detected 
in LC3-positive structures154, and it is generally indispensable for membrane fusion 
events155. Ca
2+ 
appears to have a dual role in autophagy regulation. Available evidences 
indicate that the IP3 receptors mediate a constitutive Ca
2+ 
release which is taken up by 
mitochondria, promoting ATP production and in turn inhibiting AMPK and leading to 
autophagy suppression156. Several studies have also proposed that Ca
2+ 
has a stimulatory 
function towards autophagy. When cells are under stress, Ca
2+ 
signalling is refurbished 
and results in the elevation of cytosolic Ca
2+
, in turn activating a variety of autophagy-
stimulating proteins like calmodulin dependent kinase kinase-beta (CAMKK β), which 







phosphorylation of Beclin-1, causing its dissociation from Bcl-2156. Protein kinase C 
(PKC) and extracellular-regulated kinase (ERK) are also involved in Ca
2+ 
dependent 
autophagy stimulation156. An increase in intracellular Ca
2+ 
can also activate death 
associated protein kinase (DAPK) and calpain proteases, both Ca
2+ 
dependent enzymes 




The p62/SQSTM1 (sequestosome 1) protein mediates diverse signalling pathways 
including cell stress, survival and death. The N-terminal PB1 domain of this protein 
exhibits self oligomerization, and the C-terminal UBA domain can bind to ubiquitinated 
proteins. p62 localizes in autophagosomes via LC3 interaction, and is continuously 




A growing line of evidence indicates that 
ubiquitinated proteins initially interacts with p62, then aggregation of the protein complex 
occurs in a p62-dependent manner and the aggregates are finally degraded by autophagy. 
Ablation of autophagy leads to marked accumulation of p62 resulting in the formation of 
p62-positive inclusions. Since p62 accumulates when autophagy is inhibited, and 
decreased levels can be observed when autophagy is induced, p62 may be used as a 




9. Role of autophagy in cancer 
 
The role of autophagy in cancer is a debatable topic. Autophagy serves as a protective 
role allowing the cells to survive in a changing environmental condition such as nutrient 
depreviation. Numerous line of evidence suggest an anticancer role of autophagy. The 
autophagy gene Beclin-1 is a haploinsufficient tumor suppressor gene in mice and is 




Moreover, p53 and 





Together, these findings suggest that autophagy inhibits tumor 
formation, although the pathway is still not clear. On the other hand there are growing 
evidences indicating the predominant role of autophagy in tumor progression, suggesting 
that the role of autophagy may depend on the type of tumors, the stage of tumorigeneses, 
the nature and extent of the insults. For instance, autophagy has been found to be up-
regulated during the later stages of cancer development; that would allow cell survival in 










9.1 Autophagy in melanoma progression 
 
The presence of basal levels of autophagy in melanoma has been recognized for many 
years because some melanoma cells contain autophagosomes with melanized 
melanosomes, which are readily visible under the light microscope. Melanized 
autophagosomes are the underlying basis of ‘coarse melanin,’ a long-recognized 
phenomenon by pathologists that accounts for the dark areas of melanomas seen in 
clinical presentation
179
. Non-pigmented melanomas contained similar autophagosome like 
structure but without melanin
179
. Lazova et al. showed that superficial spreading 
cutaneous malignant melanoma, cells in florid melanoma in situ (MIS) and invasive cells 
in the dermis, all appeared to be undergoing autophagy; in all these cases, 
autophagosomes were detected through immunohistochemistry using the marker LC3B 
(microtubule-associated light chain 3B); normal melanocytes as well as keratinocytes did 
not stain for LC3B, suggesting that an association between autophagy and invasion is a 
significant factor in malignant melanoma progression
177-179
. In the same line of evidence, 
Ma et. al.
180
 have recently found that patients, whose melanoma tumor had a higher 
number of autophagic vacuoles, are less likely to respond to Temozolomide and 
Sorafenib treatment and have a shorter life expectancy compared with those with a low 
autophagic index. Moreover, inhibition of autophagy by Atg5 shRNA or with chloroquine 
significantly increased temozolomide-driven cell death in cultured melanoma cells. In 
addition, they noted a high tumorigenicity in mouse xenografts and an increased invasive 
potential of cultured melanoma cells with high autophagic vesicle content. The 
widespread expression of autophagy in different melanoma cells suggests that 
maintaining an elevated autophagic flow may be important for the survival of melanoma 





9.2 Pharmacological inhibition of autophagy as an approach towards cancer 
treatment 
 
Autophagic vacuolization is not always the result of enhanced autophagy, but may also  
result from the failed elimination of autophagic debris. Multiple studies have shown that 
pharmacological inhibition of autophagy can effectively enhance tumor cell death in 
preclinical models
182, 184, 185, 196-198
.
 












Autophagy can be pharmacologically inhibited broadly in two ways, at an early stage or 
in late stage. Early-stage autophagy inhibitors like 3-methyadenine,Wortmannin and 
LY294002,target class III PI3K. Late-stage inhibitors like CQ, hydroxychloroquine 
(HCQ) or Bafilomycin A1, are lysosomotropic drugs that prevent the acidification of 




The ability of autophagy inhibition to enhance chemosensitivity and tumor regression has 
been confirmed in a murine lymphoma model, a colon cancer xenograft model, and a 
prostate cancer xenograft mouse model
184, 185-189
. Several phase I/phase II trials have been 
conducted in order to evaluate the efficacy of a combination of HCQ with other cytotoxic 
drugs, on a variety of tumor types
188, 189
. A combined therapy with the proteasomal 
inhibitor bortezomib and CQ was shown to suppress tumor growth to a greater extent than 




Phase I/II clinical trials evaluating this 




In some tumor cell lines, 
when the fusion of autophagosomes and lysosomes is blocked by the addition of 
lysosomal inhibitors (such as CQ or Bafilomycin A1), autophagic vacuoles accumulate 





observation strongly suggests that the inhibition of autophagy, either at early or late 
stages of the process, may lead to apoptosis as a result of the failure to adapt to starvation.  
 
A number of anticancer therapies, including DNA-damaging chemotherapeutic drugs, 
have been observed to induce the accumulation of autophagosomes in tumor cell lines 
and inhibition of autophagy. In vivo experiments confirmed that the inactivation of 




Although the mechanisms 
through which the inhibition of autophagy may favour cell death are not entirely clear, it 
is possible that the inhibition of autophagy results in the absence of redox equivalents, 





Inhibition of autophagy may also reduce the capacity of cells to 





















































































The seminal hypothesis of the present study is that melanoma cells over-express certain 
types of voltage-gated calcium channels, which play a critical role in the progression of 
the cell cycle and, generally, in maintaining the homeostasis of these cells. 
 
The experimental goals to rule this hypothesis are the following: 
 
 To characterize the expression of genes encoding VGCCs in human melanoma 
cell lines, biopsies and control untransformed melanocytes.  
 To demonstrate the function of the VGCCs which show a relevant expression, at 
the molecular level, in melanoma cell lines and untransformed melanocytes. 




 To analyze the value of certain types of VGCCs as targets of pharmacological 
and/or genetic approach against melanoma. That is, to study the effects of specific 
VGCC blockers and VGCC gene-knockdown on the viability of melanoma cells 
grown in vitro. 
 To explore the molecular pathways involved in VGCC-blockade/gene silencing-






































































































































Applied Biosystems(New Jersey, 
USA) 
TaqMan Universal PCR  Mastermix 
First strand c DNA synthesis kit for RT-PCR 
BD Biosciences 
(Bedford, MA, USA) 
Plates (100X20) 
Serological pipettes 
Biological Industries EZ ECL Chemiluminescence Detection kit for HRP 
Biorad Laboratories(CA,USA) 30% Acrylamide/Bis solution 29:1 
Falcon(BD Labware , USA) Serological pipet (different volume) 
Plates  100X 20 mm 
6 well plates for cell culture 
96 well plates for cell culture 
24 well plates for cell culture 
Fisher Scientific (Madrid ,Spain) Centrifuge tubes (different volume) 
Methanol 
GIBCO-Invitrogen(Carlsbad ,USA) Dulbecco’s modified Eagles medium (DMEM) 
254 medium supplemented with human melanocyte 
growth supplement (HMGS-2) 
Fetal bovine serum (FBS) 












SYBR safe DNA gel stain 
Low molecular weight protein bench mark 
Merck (Barcelona, Spain) β Mercaptoethanol 
Millipore (Bedford, MA) Polyvinylidine fluoride (PVDF) membrane 
Roche (Germany) 2-(2-Methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-
(2,4-disulfophenyl)- 2H-tetrazolium (WST-1)  







Dimethyl sulfoxide (DMSO) 
Dodecyl sodium sulfate (SDS) 
Glycerol 
Glycine 






















Panreac (Barcelona, Spain) Ethanol 
Hydrochloric acid (HCl) 
Isopropanol 
Sakura Finetechnical (Tokyo, Japan) Tissue Tek OCT 
Cascade Biologicals Inc.(Portland 
,OR,USA) 
Neonatal human epidermal melanocytes(HEMn-Lp) 





Gene Craft ( Germany) Taq DNA polymerase 
GE healthcare  50 base pair DNA ladder 




Table 6. Sequence of short interfering RNA  
 
 
Product name Sequence company 
siRNA Cav3.1 5 -́ GCGAGGCAGUUUAUGAGUUtt-3´ 
3 -́ AACUCAUAAACUGCCUCGCtg-5´ 
Applied Biosystems 


































Cav2.1 * NM_000068               Forward: CGATGCCTCAGGGAACACTTGG                                          
Reverse: CCATGTACCCATTGAGCTCACG 
197 58°C
Cav2.2 * NM_000718 Forward: CATCAACCGCCACAACAACT 
Reverse: ACATCAGAAAGGAGCACAGG 
205 58°C 




Cav3.1  NM_018896 Forward GGTCCGGCACAAGTACAACT 
Reverse CACAATGAGCAGGAACGAGA 
187 55°C 
Cav3.2  NM_021098 Forward TCGAGGAGGACTTCCACAAG 
Reverse TGCATCCAGGAATGGTGAG 
225 55°C 
Cav3.3  NM_021096 Forward GGTGTCGTGGTGGAGAACTT 
Reverse GTGCACATGGAGTGGATGAG 
173 58°C 





Forward AAACAGACTAGCAGCTCAGACTGC  
Reverse TCCTTCTGGGTAGACCTCTGGGAG  
u-473 
s-290 
   183  
63°C 
 
Acc. no.: Accession number of the amplified gene; Length: length in base-pairs of the 
PCR product; Temp.: annealing temperature used in the PCR 
*Primer sets taken from available literature: for Cav2.1 as in Wimmers et al., 2008; for 







Table 8. Antibodies 
 
 
Name of  primary 
antibody 
Molecular weight (KDa) dilutions company 
BrdU  - 1:150 Dako 
Beta Actin 45 1:3000 Sigma 
GRP-78/ BiP (ET-21) 78 1:3000 Sigma 
GADD153(F-168):SC-575 28 1:1000 Santa Cruz 
Biotechnology 
LC3 19 (LC3-I) 
17 (LC3-II) 
1:3000 Novus Biologicals 
Beclin-1  60 1:1000 Santa Cruz 
Biotechnology 
P62 47 1:4000 Novus Biologicals 
Atg5 32 (ATG5) 
54 (ATG5-ATG12) 
1:2000 Sigma-Aldrich 
Cyclin D1 36 1:1000 BD Pharmingen
TM
 
Caspase 3 19 (cleaved Caspase 3) 
17 (cleaved Caspase 3) 
1:1000 Cell Signaling 
technology 
Caspase 9 47 ( Procaspase 9 ) 
35 (Cleaved Caspase 9) 
1:1000 Cell Signaling 
Technology 
Secondary anti mouse 
antibody 
- 1:10,000 Sigma-Aldrich 
Secondary anti rabbit 
antibody 





















































































1. Cell culture 
 
Seven human malignant melanoma cell lines of cutaneous origin were obtained from the 
Department of Immunology of the Hospital Clinic de Barcelona (Spain). These cell lines 
were already being employed in human immunization protocols. M9 was derived from a 
primary tumour, whereas M16, M17, M28, M29, M36 and JG originated from malignant 
melanoma metastasis. The melanocytic lineage of these cell lines was previously 
confirmed by immunodetection of the specific melanoma cell markers S100 and HMB-45 
(see Table 9, modified from Sorolla et al., 2008)
202
. Cell lines were classified as low, 
average, (medium) or high-proliferating, depending on the time needed to double the cell 
population (table 9). The cells were cultured in DMEM medium supplemented with 10% 
foetal calf serum, penicillin-streptomycin and fungizone amphotericin B (Invitrogen, 
Carlsbad, CA, USA) at 37
◦
C and 5% CO2. Where indicated, hypoxia (2% O2, 93% N2, 
5% CO2) was achieved using an In Vivo2 hypoxic workstation (Ruskin Technologies, 
Leeds, UK).The sampling of melanoma cells was completed by additional examination of 
three metastatic tumour biopsies (B1, B2 and B3), which were performed and diagnosed 
as melanoma tumours in the Hospital Universitari Arnau de Vilanova (Lleida, Spain) 
(Table 9).These samples were obtained with the approval of the local Ethical Committee 
and a specific informed consent was used. The biopsies were frozen embedded with 
Tissue Tek OCT (Sakura Fine technical Tokyo, Japan) for cryoprotection, and maintained 
at 80
◦
C until use. Human epidermal melanocytes isolated from lightly pigmented neonatal 
foreskin (HEMn-LP) were purchased from Cascade Biologicals Inc. (Portland, OR, USA) 
and cultured according to the provider’s instructions. Melanocytes were maintained in 
Medium 254 supplemented with human melanocyte growth supplemnent or HMGS-2 
(hereafter referred as melanocyte growth media; Invitrogen) at 37
◦
C and 5% CO2. 
 
1.1 Trypsinization of adherent cells 
 
In order to facilitate subculture or harvesting, cultured cells were trypsinized under the 
commonly used procedure for trypsinization of cells in a monolayer culture. Briefly after 
reaching an adequate confluency cells were rinsed with warm phosphate buffer saline 
(PBS, pH 7.4, 37
◦
C) to eliminate traces of serum from the medium, and then incubated 
with 0.25% trypsin EDTA solution for 3-5 mins at 37
◦
C).Trypsinization was stopped by 







cells were centrifuged at 1000 rpm 5 minutes RT. The supernatant was discarded and the 
cell pellet was resuspended in 1 ml of fresh medium. From this cell suspension the cells 
were counted and subsequently seeded in adequate dishes depending on experimental 
design. 
 
1.2 Freezing and thawing cultured cells  
 
Cells were grown until approximately 80% confluency and fresh growth medium was 
added 24 hours before freezing. For freezing, the cells were trypsinized as previously 
described. After centrifugation the cell pellet was resuspended in special freezing medium 
composed of complete growth medium supplemented with 10% DMSO. The cell 
suspension was aseptically aliquoted into sterile cryovials which were placed in 
Styrofoam container. Cells underwent process of gradual freezing (48 hours at -80
◦
C) to 
avoid formation of intracellular crystals and then were transferred to a liquid nitrogen 
freezer for long time storage. Thawing out cells was done in a 37
◦
C water bath by gentle 
agitation for approximately 1-2 minutes. As soon as the content was thawed, the cryovial 
was removed from the water bath and decontaminated by spraying with 70% ethanol. All 
operations were carried out under strict aseptic conditions. The vial content was 
transferred to a centrifuge tube containing 9 ml of complete culture medium and 
centrifuged at 1000 rpm for 3 minutes. The cell pellet was resuspended with the complete 
medium and dispensed into a 100 x 20 mm culture dish for further propagation. 
 
2. Cell viability assay 
 
Cell viability was measured by the WST-1(4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-
tetrazolio]-1,3-benzene disulfonate) colorimetric assay, which assesses the ability of 
metabolically active cells to reduce water soluble forms of tetrazolium. An expansion in 
the number of viable cells results in an increase in the overall activity of mitochondrial 
dehydrogenases in the sample. The augmentation of the enzyme activity leads to an 
increase in the amount of formazan dye formed, which directly correlates with the 
number of metabolically active cells in the culture. Human melanocytes and melanoma 
cells were plated on M96 well plates at a density of 4000 cells per well. After 24 h, the 
cells were treated with the Ca
2+
 channel modulators as appropriate for further 24 h. After 







0.5 mg ⁄ ml of WST-1 reagent. Absorbance was measured at 440 nm wavelengths using a 
reference filter at 620 nm wavelengths in a microplate reader (Bio-Rad Laboratories Inc., 
Hercules, CA, USA). Viability assays were performed at least three times in independent 
experiments, using triplicate measurements in each.  
 
Cell viability was also measured using MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] (MTT), which assess the ability of metabolically active 
cells to reduce MTT. Melanoma cell lines were plated on M96 well plates at 4 x 10
3
 cells 
per well. After the corresponding treatments, cells were incubated for 45 min with 0.5 
mg/mL of MTT reagent and lysed with dimethyl sulphoxide. Absorbance was measured 
at 595 nm in a microplate reader (Bio-Rad, Richmond, CA, U.S.A.).  
 
For calculation of the EC50 values we used the Graphpad Prism statistical software, and 
fitted a Hill’s logistic equation to the concentration response data, using the following 




Where x is the logarithm of the 
concentration; and y is the response, and y starts at the bottom and goes to the top in a 
sigmoid curve.  
 
3. Calcium imaging 
 
Changes in the concentration of intracellular Ca
2+
 were measured using the membrane 
permeable acetoxymethylester form of the fluorescent dye FURA-2. The cells were 
grown on 10 g⁄ ml poly-L-lysine-coated glass coverslips for 24 h and incubated for 60 
min at 37ºC in culture medium containing 10 M of FURA-2 ⁄AM (Invitrogen). This 
procedure resulted in an even distribution of the fluorescent dye in the melanocytes and 
selected melanoma cells. The cells were rinsed with physiological solution to remove the 
extracellular dye and the coverslips were mounted on an inverted epifluorescence 
microscope Eclipse TE 200 (Nikon, Tokyo, Japan) equipped with a Spectramaster 
monochromator (Olympus, Tokyo, Japan) and a ORCA-AG CCD camera under the 
control of AQUACOSMOS software (Hamamatsu Photonics, Hamamatsu, Japan). In the 
experiments designed to measure Ca
2+
 influx, the FURA-2 dye was dually excited at 
wavelengths of 340 and 380 nm and emitted fluorescence was measured at 510 nm. 
Changes in Ca
2+







the experiments designed to measure Mn
2+
 influx, the FURA-2 was excited at the 
isosbestic (Ca
2+
 insensitive) wavelength of 360 nm and the emitted fluorescence was 
measured at 510 nm. This approach is based on the abilities of Mn
2+
 to permeate through 
Ca
2+




3.1 Recording solutions 
 
For FURA-2 recordings, cells were perfused at a rate of 4 ml/min with a Ringer 
physiological solution containing (in mM): 130 NaCl, 5 KCl, 2 CaCl2 (except in Mn
2+
-
quenching experiments), 1 MgCl2, 10 HEPES, 10 glucose, adjusted to pH 7.4 with 
NaOH. When indicated, cells were depolarized with an iso-osmotic solution in which 
NaCl was replaced by KCl up to a concentration of 130 mM. In the experiments of 
FURA-2 quenching by Mn
2+
, 200 M MnCl2 was added to a Ca
2+
-free Ringer solution. 
To demonstrate the participation of T-type channels in the constitutive Ca
2+
 entry, we 
applied the pharmacological T-type channel blocker Mibefradil, which was dissolved 
from frozen stocks to a working concentration of 10 μM in Ringer solution. In these 
experiments, which required high volumes of perfusion, we omitted the use of the highly 
specific T-type channel blocker Kurtoxin due to its limited availability. 
 
4. Polymerase chain reaction (PCR) 
 
The polymerase chain reaction is a rapid procedure for in vitro enzymatic amplification of 
a specific segment of DNA. In the present study, semi-quantitative and real time PCR 
techniques were employed. 
 
4.1 Isolation of RNA and cDNA synthesis 
 
Total RNA was prepared from each human melanoma cell line ⁄ biopsy and melanocyte 
cell culture using TRIzol reagent (Invitrogen) according to manufacturer’s instructions. 
The final concentration of RNA in the sample was determined by a Nanodrop (ND-1000) 
spectrophotometer. Messenger RNA was reverse-transcribed (RT) to cDNA (42
◦
C for1 h, 
50
◦
C for 1 h and 90
◦
C for 10 min) using random hexamers and Superscript II reverse 







reactions were carried out to establish that the target RNA was not contaminated with 
DNA. 
 
4.2 Semi-quantitative PCR 
 
The cDNA product was used as a template for subsequent PCR amplifications for VGCC 
pore-forming subunits. Primers were designed to be complementary to the published 
human sequences for each of the pore-forming subunits of the VGCCs and to include as 
many known variants as possible. Where indicated, RT-PCR primer sequences were 
obtained from the available scientific literature. The housekeeping gene GAPDH was 
used as a loading control. Table 7 contains primer sequences, product sizes and PCR 
conditions. For each set of primers, RT-PCR was repeated a minimum 3 times in 
independent samples. 20L of reaction mixture contained 10 x reaction buffer (2L), 
1.25μL MgCl2 (25mM), 1µL dNTPs (10mM), sterile water (22.55µL) and Taq 
polymerase (0.2μL). The PCR reaction was run in a thermocycler (Gene Amp
®
 PCR 
System 2700 from Applied Biosystems). 38 cycles of PCR amplification include 
initialization at 95
◦
C for 5 minutes, denaturation at 94
◦
C for 30 seconds, annealing 
(temperature as specified in table 7) for 30 seconds, elongation at 72
◦
C for 30 seconds and 
final elongation at 72
◦
C for 7 minutes. Equal volumes of PCR products (20μL) were 
loaded and electrophoresed in a SYBR Safe (Life Technologies)-stained 3% agarose gel. 
The images of agarose gel illuminated by UV light were taken using Kodak EDAS 290 
imaging system with Kodak 1D 3.6 software. Experiments were performed in triplicates 
and representative images were presented. 
 
4.3 XBP-1 splicing assay 
 
The method used for detection of spliced and unspliced mRNAs transcribed from the 




Briefly the RT-PCR product of XBP-1 
mRNA was synthesized primers using primers as described in table number 6 with the 
following PCR protocol: 35 cycles of PCR amplification including initialization at 94
◦
C 
for 4 minutes, denaturation at 94
◦
C for 10 seconds, annealing at 63
◦
C for 30 seconds, 
elongation at 72
◦
C for 30 seconds and final elongation at 72
◦
C for 10 minutes
248, 249
. XBP-







XBP-1 mRNA. The cleaved fragment contains a Pst-1 restriction site, and the extent of 
XBP-1 processing can be thus evaluated by restriction analysis. PCR products were then 
incubated with Pst-1 restriction enzyme for 2.5 hours at 37°C, and the resulting digests 
were separated in 3% agarose gels. The PCR products derived from nonspliced XBP-1 
mRNA were digested in two bands of 290 bp and 183 bp. In contrast the products 
amplified from spliced XBP-1 mRNA were resistant to digestion and remained 473 bp 
long. 
 
4.4. Quantitative PCR (Real Time PCR) 
 
Real-time PCR amplification with gene specific primers for human voltage-gated calcium 
channel genes CACNA1C (Cav1.2), CACNA1D (Cav1.3), CACNA1G (Cav3.1), 
CACNA1H (Cav3.2), CACNA1I (Cav3.3) and an endogenous control (GAPDH) were 
performed with using a TaqMan universal PCR master mix in an ABI prism 7000 
sequence detection system (Applied Biosystems). This detection system determines the 
absolute quantity of a target nucleic acid sequence in a test sample by analyzing the cycle 
to cycle change in fluorescent signal as a result of amplification during PCR. 20 cycles at 
95ºC for 15 seconds and 60
◦
C for 1 minutes were performed. All assays were based on 
TaqMan hydrolysis probes labelled with FAM (green fluorescent fluorophore 6-
carboxyfluorescein). The results were obtained in the form of a Ct value (cycle 
threshold), which represents the cycle number of the PCR during which the exponential 
growth of PCR product starts. Therefore, the higher the expression of the gene in the 
sample, the lower Ct value will be obtained as a result. The relative quantity of mRNA for 
every gene was calculated in the following manner: ∆Ct=Ct of the target gene - Ct of 
GAPDH gene; ∆(∆Ct) = ∆Ct of sample - ∆Ct of the control. Relative mRNA levels were 
calculated and expressed as fold induction over contralateral controls (value=1.0) 
following the formula 2
-∆(∆Ct)
. All samples were amplified in triplicate and data were 












5. Propidium iodide (PI) staining and flow cytometry 
 
Following treatment, approximately 1x10
6 
cells were fixed in 70% ethanol for at least 1 
hour on ice. The cells were then resuspended in 2 ml of cell cycle buffer (20µg ⁄ ml PI) in 
PBS, containing 0.1% Triton X-100 and 50 µg ml
-1
 RNase A for 1 h at 37
◦
C. PI 
fluorescence emission was measured with a FACS Canto II flow cytometer (BD 
Biosciences, Franklin Lakes, NJ, USA), and cell cycle distribution was analysed with 
MODFIT LT (Verity Software House, Topsham, ME, USA) and WinMDI 2.9 software 
(The Scripps Research Institute, La Jolla, CA, U.S.A.).   
 
6. 5-Bromodeoxyuridine incorporation 
 
The BrdU Cell Proliferation Assay detects 5-bromo-2’-deoxyuridine (BrdU) incorporated 
into cellular DNA during cell proliferation using an anti-BrdU antibody. When cells are 
cultured with labelling medium that contains BrdU, this pyrimidine analog is incorporated 
in place of thymidine into the newly synthesized DNA of proliferating cells. For the 
determination of DNA, cells were incubated with 6 µmol L
-1
 of 5-Bromodeoxy- uridine 
(BrdU) (Sigma Aldrich) for 2 hours and then fixed with 4% paraformaldehyde. After 
DNA denaturing with 2 M HCl for 30 min and neutralization with 0.1 M Na2B4O7 (pH 
8.5) for 2 min, cells were blocked in phosphate-buffered saline (PBS) solution containing 
5% horse serum, 5% foetal bovine serum, 0.2% glycine and 0.1% Triton X-100 for 1 
hour. Subsequently, cells were subjected to indirect immunofluorescence with a mouse 
anti-BrdU monoclonal antibody (Dako, Glostrup, Denmark), and fluorescein 
isothiocyanate-conjugated antimouse secondary antibody (Molecular Probes, Eugene, 
OR, U.S.A.). Nuclei were counterstained with 5 µg mL
-1
 Hoechst 33258 and cells were 
visualized under an epifluorescence microscope (Leica Microsystems, Wetzlar, 
Germany). The magnitude of the absorbance for the developed colour is proportional to 
the quantity of BrdU incorporated into cells, which is a direct indication of cell 
proliferation. 
 
7. Western blot analysis 
 
At the end of the corresponding treatments, the melanoma cell lines were washed twice 







buffer [2% Sodium dodecyl sulphate (SDS), 125 mM Tris-HCl, pH 6.8]. Protein extracts 
were denatured by heat shock at 95ºC for 3 min and quantified by a Lowry assay (Bio-
Rad). Equal amounts of proteins were subjected to SDS–polyacrylamide gel 
electrophoresis (PAGE) and transferred to polyvinylidene difluoride membranes 
(Millipore, Bedford, MA, U.S.A.). Non-specific binding was blocked by incubation with 
TBST (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20, pH 7.4) plus 5% nonfat milk. 
Immunodetection was performed using the appropriate primary antibodies. Immunoblots 
were developed with an appropriate secondary Peroxidase-conjugated antibody, and the 
bound antibody was visualized using the chemiluminescent substrate Super Signal 
(Thermo Scientific, Rockford, U.S.A.) and EZ-ECL (Biological Industries, Israel). Levels 
of -actin signal were used to verify equal protein loading in each lane. Some of the 
images were digitally acquired by VersaDoc Imaging System Model 4000 (Bio-Rad).  
 
8. Gene knockdown by siRNA 
 
Briefly, M16 and JG melanoma cells were plated at 50 % confluence. Transfection was 
performed in OptiMEM

 medium containing 50-100 nM siRNA and Lipofectamine 
RNAiMAX reagent (Invitrogen) following the manufacturer’s instructions. After 8 h 
the medium was changed to regular culture medium. To increase the efficiency of the 
knockdown, a second transfection was performed the following day. Cells were processed 
24 h after the second transfection. In each experiment, the knockdown efficiency was 








 Red DND-99 is a cell-permeant red-fluorescent dye for selective lysosomal 
staining with a minimum background. It consists of a fluorophore linked to a weak base 
that is only partially protonated at neutral pH. This allows LysoTracker
®
 probes to freely 
permeate cell membranes enabling them to label live cells. The 70%-confluent cells were 
treated with calcium channel blockers. At the appropriate time points, the growth medium 
was removed and the cells were labelled with LysoTracker
®
 Red DND-99 (100 nM) for 2 
minutes, washed with HBSS and further labelled with Hoestch 33258 (5 g mL
-1
) for 







were washed twice with HBSS at room temperature and visualized immediately under an 
epifluorescence microscope (Leica Microsystems, Wetzlar, Germany). 
 
10. Hoestch 33258 staining 
 
The cells were treated with drugs and, at the appropriate time, the growth medium was 
aspirated and the cells were washed twice with warm PBS 1X. The cells were then fixed 
with paraformaldehyde in PBS at RT and cold methanol was added for permeabilization. 
The cells were kept at room temperature for 20 minutes, rinsed thoroughly 3 times with 
PBS and 5 µg ml
-1
 of Hoechst staining were added for further 15 minutes at RT. Finally, 
the cells were rinsed 3 times with PBS and visualized under an epifluorescence 
microscope (Leica Microsystems, Wetzlar, Germany) 
 
11. Statistical analysis 
 
Statistical significance was checked, as appropriate, by application of a Shapiro–Wilk 















































































Functional Expressions of Voltage Gated 










































1. Expression of VGCCs in control normal melanocytes and melanoma cells 
Standard reverse transcriptase PCR (RT-PCR) was performed to determine the expression 
of the three gene families encoding VGCCs in three fast-growing metastatic melanoma 
cell lines (M28, M36, JG), two average-growing metastatic cell lines (M16, M17), one 
slow-growing metastatic melanoma cell line (M29), one very slow growing primary 
tumour-derived cell line (M9) and three tumour biopsies (named B1, B2 and B3). In the 
first set of data, we compared the expression of VGCCs in control normal melanocytes 
and three selected melanoma cell lines (M16, M28 and JG) that were cultured in parallel, 
using melanocyte growth medium (see Methods) (Figure 8A). As the Ca
2+
 imaging 
experiments demonstrated the functional relevance of L-type and T-type channels in the 
melanoma cells (see below), we additionally checked up the expression of these channels 
by quantitative RT-PCR (Q-PCR) (Figure 9). Subsequently, we extended the analysis of 
VGCCs expression to all melanoma cell lines grown in standard high-glucose DMEM, 
and to the biopsies (Figure 8B). 
1.1 L-type channels 
We tested the expression of L-type Ca
2+
 channels by RT-PCR using specific primers for 
Cav1.2 and Cav1.3 pore-forming subunits. Both channel isoforms have been suggested 
recently to play a role in the Ca
2+





Expression of Cav1.2 channels was found to be widespread, with 
positive results in all melanoma cells but two metastatic cell lines (M17 and JG), whereas 
the channels were undetectable in control normal melanocytes. In contrast, Cav1.3 
channels were ubiquitously expressed in all metastatic cell lines, the primary tumour and 
the biopsies, while showing the highest levels in control normal melanocytes (Figures 8 
A-B, Figure 9). 
1.2 N-type, P-Q-type and R-type channels 
Melanocytes are specified from pluripotent neural crest cells that delaminate from the 
developing neural tube in the initial stages of development
208
. Because of the common 
embryological origin with peripheral nervous and neuroendocrine tissue, we examined 
the expression of Ca
2+








Figure 8. RT-PCR expression analysis of human genes encoding VGCCs. (A) comparison  of 
VGCC expression in control normal melanocytes(M) and three selected melanoma cell types 
(M16, JG and M28) cultured in melanocyte growth media. (B) Extended analysis for the same 
melanoma cell lines as in (A), plus M9, M29, M17 and M36, all cultured in melanoma standard 
high-glucose medium. The analysis included three biopsies taken from metastatic melanomas (B1, 
B2, B3). Results were validated at least three times from independent RT-PCR reactions. The first 
lane shows the MW markers, the 250-bps band being the most prominent.) RT- is the sample 
without reverse transcriptase. 
 







Table 9. Classification of the melanoma-derived cell lines according to their origin 
and proliferation rate, and expression of VGCCs types 
 
Origin Samples T-type  L-type N, P-Q, R-type 
Untransformed Melanocytes None Cav1.3 Cav2.1 
Cav2.2 (low) 
Cav2.3 
























 JG (HPR) Cav3.2 
Cav3.3 
None Cav2.1 









































Our results show that control 
normal melanocytes expressed transcripts for Cav2.1 and Cav2.2 (low expression) and  
Cav2.3 channels (figure 8A). Melanoma cells also expressed the three Cav2 isoforms, with 
the following exceptions: Cav2.2 was not amplified from M17 and JG metastatic cell 
lines; Cav2.3 was not amplified from M16 and JG metastatic cell lines or the M9 primary 
tumor cell line (figure 8B). 
1.3 T-type channels 
Low voltage-activated T-type channels are involved in cell proliferation and the 
expression of T-type channel isoforms is up-regulated in different tumours
43,76 
. As shown 
in Figure 8B, the expression of T-type channels was detected in all melanoma cell lines 
and biopsies, although we found qualitative and quantitative differences in the expression 
of the different isoforms: the M9 primary tumour cells, the M29 and M16 metastatic cells 
and the B3 biopsy expressed the highest levels of Cav3.1, while showing lower levels of 
Cav3.2 transcripts. Interestingly, this pattern of expression was linked to a slower 
proliferation rate (Table 9, Figure 11). Only two cell lines derived from skin metastasis 
(M28 and M29) and two melanoma biopsy samples (B1, B2) expressed Cav3.3 channels, 
with no concomitant decrease in the level of Cav3.2 expression. Importantly, very low 
levels of Cav3.1 transcripts were detected as the only T-type channel isoform expressed in 
control normal melanocytes (Figures 8A and 9). As stated above, for these RT-PCR 
experiments we used three melanoma cell lines (M16, M28 and JG) as positive controls, 
cultured in parallel with control normal melanocytes in melanocyte growth medium, 
although in these conditions their proliferation rate was significantly lower than that 
attained in standard high-glucose medium (data not shown). 
2. Moderate hypoxia induces the selective up-regulation of T-type and L-type 
channels 
Physiological skin hypoxia has proved to be a relevant factor for melanocyte 
transformation and melanoma development
210
. It had been shown that Cav3.2 channels 
are upregulated via the activation of hypoxia inducible factor-2 (HIF-2) in PC12 cells
86
 
and that Cav3.1 channels are down-regulated by HIF-1 in neonatal cardiomyocytes
211
 
Therefore, we decided to test whether the expression of Cav3 channels was regulated by 








Figure 10. Hypoxic up-regulation of T-type channel isoforms in control normal melanocytes and 
a selection of melanoma cell lines (M16, JG and M28). RT-PCR was performed to amplify T-type 
channel transcripts from the cells incubated in a normoxic (N) or hypoxic (H, 2% O2) atmosphere 
for 24 h. (A) None of the transcripts for Cav3 channel isoforms was amplified from control normal 
melanocytes, irrespective of the O2 concentration. (B) Induction of Cav3.1 and Cav3.2 channel 
transcripts by hypoxia in fast-growing JG and M28 metastatic melanoma cells. (C) VGCC gene 
expression analysis by Q-PCR in the same cell lines as above. Histograms show mean fold 
expression in hypoxia related to the mean of the normoxic control (‘ratio to control’). Absence of 
bars indicates undetectable levels in control conditions. Data was obtained from triplicate 
measurements in each of three to six independent experiments. *Significant differences related to 
control group (P < 0.05). RT-, minus reverse transcriptase 
JG, M16 and M28 cells at 70–80% confluence were placed in a hypoxic incubator and 
exposed to 2% O2 for 24 h. Control plates were kept in a normoxic state and processed in 
parallel. RT-PCR data showed the up-regulation of selective T-type channels by hypoxia, 
which was specific to the cell type. Thus, Cav3.1 (and Cav3.2 to a minor extent) were up-
regulated in fast-growing JG and M28 cells but not in average-growing M16 cells 
(Figure 10B). Hypoxia did not induce the up-regulation of any of the three T-type channel 
isoforms in control normal melanocytes but did induce a down-regulation of the already 
low levels of Cav3.1 (Figure 10A).  
We also checked the effect of a moderate hypoxic environment on the expression levels 







Cav1.2 channels was increased in the JG cell line compared with normoxia conditions. In 
contrast, the expression of Cav1.3 channels was slightly reduced by hypoxia in control 
normal melanocytes (Figure 10A).We complemented these data by performing a series of 
Q-PCR experiments. This approach confirmed that the up-regulation of Cav3.1 (up to 60-
fold) and Cav3.2 (≈two-fold) T-type channels by hypoxia was restricted to the fast-
proliferating JG and M28 cell lines, whereas the expression of both isoforms was reduced 
by hypoxia in medium-proliferating M16 cells. Consistent with the RT-PCR data, these 
experiments also showed that the expression of the L-type Cav1.2 channels was increased 
by hypoxia in JG cells (≈three-fold), remaining unchanged in M16 and M28 cells, 




Figure 11. Cell cycle analysis by flow cytometry (PI staining) of JG, M28 and M16 melanoma 







3. Functional expression by calcium imaging 
 
To examine the functional expression of the VGCCs and their contribution to Ca
2+
 influx, 
we performed a series of Ca
2+
 imaging experiments using the membrane permeable 
acetoxymethylester (AM) form of the fluorescent dye FURA-2 in a dynamic fluorescence 




Figure 12. Increases of cytosolic Ca
2+
 in response to sequential membrane depolarization, and 
pharmacological activation of L-type channels in control melanocytes (M) and melanoma cells 
(JG, M16 and M28). Cytosolic Ca
2+
 levels in Fura-2-loaded cells were monitored as the 
fluorescence ratio at 340 and 380 nm (F340 ⁄ F380). In ‘double pulse’ experiments, KCl-driven 
depolarization and Bay K 8644 application failed to induce changes in the F340 ⁄ F380 ratio of 
control melanocytes, and only minor increases could be recorded in JG cells. However, both 
stimuli elicited consistent increases of F340 ⁄ F380 in the M28 and M16 melanoma ma cell lines, 
demonstrating the functional expression of L-type Cav1.2 channels. (A) Average F340 ⁄ F380 data 
points from six to 12 cells recorded in a single experiment, as indicated. Standard deviation 
values are represented as error bars every 50 points, for clarity. (B) Fold increase of the F340 ⁄ 
F380 ratio values induced by paired-KCl and Bay K 8644 pulses. Values are represented as 







The following different experimental paradigms were used to demonstrate the functional 
expression of high and low voltage-activated channels. KCl-mediated depolarization did 
not induce detectable changes in the cytosolic Ca
2+
 levels in melanocytes, with only small 
elevations in melanoma JG cells. In contrast, high K
+
 triggered consistent increases of the 
F340/F380 ratio in Cav1.2-expressing M16 and M28 cells. The addition of Bay K 8644 
(an L-type channel activator) resulted in equivalent increases of F340/F380 in M16 and 
M28 cells, indicating that L-type Cav1.2 channels were the main carriers of 
depolarization-mediated Ca
2+
-influx (Figure 12 A,B). All M16 and M28 melanoma cells 
responded to the high K
+





Figure 13. Panel A and B shows cytosolic Ca
2+
 increases in melanoma cells, secondary to 











Often, either the depolarizing or the pharmacological stimuli triggered secondary 
increases of the intracellular Ca
2+
, suggesting a coupling of L-type channels to the 
intracellular Ca
2+
 reservoirs (Figure 13 A, B). Moreover, M16 cells at normal resting 
membrane potential also showed intracellular calcium oscillations which were largely 
decreased with the use of Mibefradil (Figure 14). 
 
Figure 15. Basal Mn
2+
 influx and its inhibition by Mibefradil. Fura-2-loaded cells were 
exposed to 200 µM MnCl2 dissolved in a Ca
2+
-free Ringer solution, as indicated. The 
Mn
2+
-induced decrease of the normalized Fura-2 fluorescence was recorded at the 
isosbestic (Ca
2+
 independent) excitation wavelength (360 nm). (A) Comparison of the 
Mn
2+
-induced quenching of control normal melanocytes (open circles), M28 (closed 
circles) and M16 (open triangles) Fura-2-loaded cells. (B) Mn
2+
-induced quenching of 
Fura-2 fluorescence in M28 melanoma cells in the absence (closed circles, same curve as 
in A) and presence of Mibefradil (open circles), displaying a much slower time course. 
(C) Mn
2+
-induced quenching of Fura-2 fluorescence in M16 melanoma cells in the 







(10µM), which again slowed down of the quenching. Traces shown in (A–C) were 
obtained by averaging three independent experiments. (D) Quantification of the Mn
2+
-
induced quenching rate of all analyzed cell types as the time taken for the fluorescence 
signal to decay to 67% of the initial value (decay time constant). Histogram bars 
represent mean ± SD values from at least three independent experiments (n = 20 for 
melanocytes, n = 28 for M28 cells, n = 29 for M28 cells in the presence of Mibefradil, n 
= 40 for M16 cells, n = 27 for M16 cells in the presence of Mibefradil). *Statistical 
significance of P < 0.001 achieved by application of the Mann– Whitney rank sum test 
(means compared: melanocytes versus M28 cells, M28 cells versus M28 cells in the 





 quenching at the FURA-2 isosbestic point 
The function of low voltage-activated Ca
2+
-channels was confirmed by measuring the rate 
of Mn
2+
 influx into the cells, following the approach first described by Jacob in 1990 (see 
Methods). A rapid quenching of the FURA-2 fluorescence (excitation at the Ca
2+
-
insensitive excitation wavelength of 360 nm) resulted from 200 μM Mn
2+
 perfusion in the 
two tested melanoma cell lines, M16 and M28, in contrast to a 10-fold slower decay of 
the fluorescence in control normal melanocytes (figure 15 A,D). This result is consistent 
with the increased expression of T-type channels in melanoma cells, compared with 
melanocytes. Furthermore, when we included the T-type channel blocker Mibefradil in 
the perfusate for M16 and M28 melanoma cells, the rate of fluorescence quenching by 
Mn
2+
 was four- to five-fold slower, indicating the participation of T-type channels in the 
constitutive influx of divalent ions (15B,C). 
5. Role for T-type channels in melanoma cell cycle progression  
 
We further studied the effects of T-type channel blockers on the viability of melanoma JG 
cells by analyzing the DNA content after propidium iodide staining using flow cytometry. 
T-type channel blocker Kurtoxin induced a significant increase of the percentage of cells 
at the G1 phase, while reducing the percentage of cells at the S phase, which indicates cell 
cycle arrest (Figure 16A). To ascertain a direct role of Cav3 channels in the regulation of 
cell cycle progression, we performed a set of siRNA-mediated Cav3.1 knockdown 
experiments in M16 cells and Cav3.2 knockdown experiments in JG cells. Q-PCR 







Cav3.2 transcripts in JG cells compared with the cells transfected with control siRNA 
(Figure 16D). These reduced levels of Cav3.1 and Cav3.2 genes induced cell cycle arrest 
at the G1 and S phases (Figure 16B,C), in a pattern similar to that induced by Kurtoxin, 
albeit to a lesser extent. 
 
Figure 16. Flow cytometry analysis and cell cycle distribution of JG and M16 melanoma 
cells: effect of T-type channel pharmacological blockade and gene silencing. (A) JG cells 
were incubated with 250 nM Kurtoxin for 24 h. Kurtoxin treatment slowed down the cell 







the percentage of proliferating (S phase) cells. (B) siRNA-mediated Cav3.1 knockdown 
halted the progression of cell cycle from G1 to S phase of M16 melanoma cells. (C) 
Similarly, siRNA mediated Cav3.2 knockdown in JG melanoma cells promoted cell cycle 
arrest at the G1 and S phases. (D) Q-PCR analysis of the level of Cav3.1 and Cav3.2 
knockdown in M16 and JG cells, respectively, for the experiments displayed in (B) and 
(C). (A–C, left and center) Graphs display the cell cycle profiles of representative 
experiments.(A–C, right) Histograms for the mean values (±SEM)(n=3) of the different 
cell cycle phases using flow cytometric analysis. *Significant differences related to 
control group (P < 0.05). 
 
6. Cell proliferation in hypoxia 
 
Having shown that hypoxia regulates T-type channel expression, and that T-type channels 
are directly involved in the melanoma cell cycle progression, we next examined the effect 
of hypoxia on the cell cycle parameters.  
 
A 2% O2 atmosphere (applied for 24 h) had opposite effects on the growth rate, 
depending on the melanoma cell type: the percentage of proliferating M16 cells was 
reduced (Figure 17A) whereas the percentage of proliferating JG cells was increased 
(Figure 17B). These opposite effects of hypoxia on the proliferation rate of M16 and JG 
cells correlate with the opposite effects of hypoxia on T-type channel expression in these 
cell types (Figure 10). 
 
To further elucidate the relationship between hypoxia, T-type channels expression and 
proliferation rate, we silenced Cav3.1 and Cav3.2 genes in JG cells subject to hypoxia. 
Under these conditions the Cav3.1/Cav3.2 expression ratio is increased by about 30-fold 
(Figure 10C). The transfection of Cav3.1 siRNA completely prevented its hypoxia 
mediated up-regulation and, in fact, the Cav3.1 transcripts were reduced to a 57% of the 
normoxia levels (Figure 18A). In comparison, the Cav3.2 transcripts were reduced to 30% 
of the normoxia levels in the JG cells transfected with Cav3.2 siRNA (Figure 18A). Both 
siRNAs were able to reverse the hypoxia-mediated effects on cell cycle parameters and or 
Cav3.2 knockdown, the percentage of cells arrested at the G1/S phase was significantly 















Figure 17.  Flow cytometry analysis and cell cycle distribution of JG and M16 melanoma cells: 
effect of hypoxia. (A, Left and center graphs) Representative profiles for M16 cells grown in 
normoxia and 2% O2, respectively. Hypoxia induced a small increase of the percentage of cells in 
the G1 phase, and a concomitant reduction of cells in the proliferative S phase. (B, Left and 
center graphs) Representative profiles for JG cells grown in normoxia and 2% O2, respectively. 
Hypoxia induced G1-S progression, contrary to the effect in M16 melanoma cells. (A–B, right) 
Histograms summarize data for cell cycle parameters in M16 and JG melanoma cells, 









Figure 18. The knockdown of Cav3.1 and Cav3.2 T type channels prevents hypoxia-
induced JG melanoma cell proliferation. 
 
7. Effect of the pharmacological blockade of VGCCs on viability of melanoma cells 
To investigate a possible role of VGCCs in melanoma cell proliferation and survival, we 
examined the effect of VGCC blockade on cell viability. We performed WST-1 metabolic 
assays on a selection of melanoma cell lines (M16, JG, M28) treated with some of the 
most specific VGCC blockers available: the neurotoxins Kurtoxin (T-type channel 
blocker), ω-Agatoxin IVA (P-Q type channel blocker), ω-Conotoxin GVIA (N-type 
channel blocker), rSNX-482 (R-type channel blocker) and the Dihydropyridines 
Nimodipine and Nifedipine (L-type channel blockers).  
After treatment for 24 hours, Kurtoxin had the strongest effect and reduced the viability 
of all melanoma cells by an average of 38–41%. Kurtoxin treatment was non-effective in 
control normal melanocytes (non-significant 3% reduction of viability, consistent with the 
lack of expression of T-type channels in these cells. In contrast, L-type channel blockers 
Nimodipine and Nifedipine negatively affected the viability of both control normal 
melanocytes (11 and 6%, respectively) and melanoma cells (12–15 and 8–10%, 
respectively. The rest of the VGCC channel blockers also had a moderate effect on 











Figure 19. Effect of VGCC pharmacological blockers on cell viability. The viability of 
melanoma cells was measured using the WST-1 proliferation assay. Absorbance values at 
440 nm, obtained from cells subjected to the different treatments, are expressed as the 
percent reduction with respect to control untreated cells. T-type channel blocker Kurtoxin 
(KTx, 250 nM) did not significantly affect the viability of control normal melanocytes, 
consistent with the lack of expression of T-type channels in these cells (Figures 8 and 9). 
In contrast, Kurtoxin induced a similar reduction of viability in all cell lines tested (M28, 
M16 and JG, values ranging from 38 to 41% reduction in viability). Blockers specific for 
L-type (Nimodipine and Nifedipine, 10 µM), P-Q-type (-Aga-IVA, 500 nM), N-type (-
Cntx, 1 µM) and R-type (SNX-482, 250 nM) channels had a moderate effect on the 
viability of melanocytes and melanoma cell lines, ranging from 6 to 15% reduction. Three 
to four independent experiments were performed per cell type and treatment, using 
parallel controls and triplicate measurements of each. *Significant differences related to 
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1. Effect of Mibefradil and Pimozide on cellular viability  
The experiments shown in the previous section suggested that T-type channel blockade 
might be a valid approach to tackle melanoma progression. We thus decided to test the 
effect on melanoma cells of T-type channel blockers which have been or are currently 
used in clinical practice, such as the anti-hypertensive/anti-anginal Mibefradil (banned by 
the Food and Drug Administration (USA) in 1998 due to interactions with certain 
hypolipemic drugs, but reintroduced in 2008, 2009 and 2010 for the treatment of breast, 
prostate and glioma tumours), and the neuroleptic Pimozide.  
We first studied the effect of these clinically relevant T-type VGCC blockers on 
melanoma cell viability, by performing a concentration-dependency study: the human 
melanoma cell lines M9, M29, M16, M17, JG, M28, M36 were exposed to increasing 
concentrations of Mibefradil for 24 h at 37
◦
C and, and the activity of the mitochondrial 
dehydrogenase enzyme was measured by the MTT metabolic assay (Figure 20A). Parallel 
experiments were performed with Pimozide (Figure 20B). Both Mibefradil and Pimozide 
reduced cell survival in a concentration-dependent manner in all tested cell lines. In 
primary tumor-derived cell lines and slow and medium growing metastatic melanoma cell 
lines, the EC50 for Mibefradil on survival ranged from 6.1 to 7.0 M; in the same cells, 
the EC50 for Pimozide was from 4.3 to 5.9 M. Fast-growing metastatic melanoma cell 
lines showed a higher sensitivity to both drugs, with Mibefradil EC50 values between 2.8 
to 3.1 M, and Pimozide EC50 values between 2.3 to 2.8 M. Having tested that 
Mibefradil and Pimozide were effective in reducing the viability of melanoma cells, we 
next wondered if the main parameter contributing to viability loss was the proliferation of 
the cells, like for Kurtoxin at 24 hours treatments. In fact, under phase contrast 
microscopy, the appearance of shrunk and floating cells in the culture dishes treated with 
drug concentrations > 1 M suggested that there was a significant cell death. 
2. Mibefradil induces cell cycle arrest and a reduction of the proliferation rate  
Based on the preliminary assays where we observed a strong growth inhibitory effect of 
Mibefradil and Pimozide in a panel of melanoma cells, we tried to determine the 
molecular mechanisms underlying the anti-proliferative activity of these drugs, by flow 
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Figure 20. Mibefradil and Pimozide induce a decrease in cell viability in a panel of melanoma 
cell lines. Melanoma cells from either primary or metastatic tumours (see table 9) were treated 
with increasing concentrations of Mibefradil (panel A) and Pimozide (panel B) for 24 h.Cell 
viability was assessed by 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. 
Results are expressed as mean ± SE percentage of the control values. 
representative cell lines for further study, because they displayed a differential profile of 
VGCCs expression, in addition to a differential proliferation rate. M16 is a medium 







JG is a fast growing malignant melanoma cell line strongly expressing the Cav3.2 isoform 
(Table 9, Figure 8). 
Earlier, we had found that 250 nM Kurtoxin induced a decrease in the percentage of JG 
cells in the S phase (Figure 16A). This result encouraged us to check the effect of other 
pharmacological blockers of T-type channels on human melanoma cells. M16 and JG 
cells were treated with Mibefradil and Pimozide for 24 hours, and the DNA content was 
analysed by propidium iodide staining and flow cytometry (Figure 21). We found that 
Mibefradil and Pimozide not only induced a decrease in the number of cells at the S 
phase, but remarkably, also induced a dramatic augmentation of the number of cells in the 
sub-G1 phase, hallmark of apoptotic cell death, in line with our light microscopy 
observations reported above. 
To complement the analysis of the T-type channel blockers antiproliferative effect, BrdU 
incorporation assays were performed in two representative cell lines. Both M16 and JG 
melanoma cells treated with Mibefradil and Pimozide for 24 hours presented a clear 
decrease in the anti-BrdU staining compared with untreated cells (Figure 22).  
As the treatment of M16 and JG cells with Mibefradil and Pimozide induced cell cycle 
arrest at the G1 phase, we next assessed the effect of Mibefradil and Pimozide on cell 
cycle regulatory molecules involved in G1 to S phase progression. Consistent with our 
previous observation, the expression of cyclin D1, a CDK kinase regulator that induces 
the G1-S transition, was found down-regulated when the cells were treated with either T-
type channel blocker for 24 hrs (Figure 23). 
3. Mibefradil and Pimozide trigger apoptosis  
We set on to explore the molecular pathways leading to Mibefradil/Pimozide- induced 
cell death. The two representative melanoma cell lines (M16, JG) were treated with 
Mibefradil and Pimozide for 24 hrs, and nuclei morphology was determined by Hoechst 
33258 staining. As expected, both T-type channel blockers prompted a drastic decrease in 
the number of total nuclei, in parallel to a relative increase in the number of pycnotic 









Figure 21. Flow cytometry analysis and cell cycle distribution of JG and M16 cells treated with 
Mibefradil and Pimozide.M16 (panel A) and JG cells (panel B) were incubated with 10µM 
Mibefradil and Pimozide for 24 h after which DNA content was analysed by propidium iodide 
staining and flow cytometry. These drugs slowed down the cell cycle arrest by concomitantly 
increasing the percentage of cells at the sub G1 phase and decreasing the percentage of 
proliferating (S phase) cells. Histograms display the cell cycle profiles of representative 
experiments.(figure A and B).Graphs represent mean values (±SEM)(n=3) of the different cell 










Figure 22. Mibefradil and Pimozide decrease proliferation of melanoma cells. M16 (panel A) and 
JG cells (panel B) were incubated with Mibefradil (10µM) and Pimozide (10µM) for 24 hrs. 
Proliferating cells showing 5-bromodeoxyuridine incorporation are bright red in colour, nuclei 
are counter stained with Hoechst 33258.Less number of BrdU positive treated  cells indicate that  




Figure 23. Mibefradil and Pimozide induce downregulation of Cyclin D1 in M16 and JG cells. 
Whole cell lysate of M16 and JG cells treated with Mibefradil and Pimozide for 24 hrs were 
analysed by western blotting. Panel A shows prominent downregulation of Cyclin D1 expression 
in M16 cells treated with Mibefradil and Pimozide.Panel B shows similar effect of the above 
mentioned drugs in JG cells. .β actin was used as loading control. 
 
Next, we assessed the involvement of caspases by Western blot. In M16 and JG cell lines, 
Mibefradil or Pimozide triggered the cleavage of initiator procaspase 9 and effector 







mitochondrial death pathway, which is often accompanied by the release of proapoptotic 
factors such as cytochrome c into the cytoplasm and subsequent binding to Apaf-1, 
resulting in apoptosome activation of Caspase 9 and subsequent cleavage (and activation) 
of Procaspase 3. 
                      
  
Figure 24. M16 (panel A) and JG (panel B) cells incubated with Mibefradil and Pimozide for 24 
hrs were stained with Hoechst 33258.Deep pycnotic apoptotic nuclei were visible in the treated 




Figure 25. Mibefradil and Pimozide trigger apoptosis by caspase processing in melanoma cells. 
M16(panel A) and JG cells(panel B) were exposed to 10 µM of Mibefradil and Pimozide  for 24 
hrs.Total protein extracts were subjected to Western blot analysis to monitor the expression of 







4. T-type calcium channel blockers and RNAi-mediated gene silencing of Cav3.1 and 
Cav3.2 channels induce endoplasmic reticulum stress  
  
During certain stages of tumorigenesis, Ca
2+
-homeostasis deregulation together with an 
inhospitable environment compromise the protein folding function in the ER and unleash 
the Unfolded Protein Response. That way, the UPR is an adaptive response and their 
markers are associated to malignity and recurrence in a number of tumors, including 
melanoma
212. 
Nonetheless, a sustained UPR may promote either apoptotic death or cell 
survival throughout a macroautophagic process, depending on the cell type and stimuli 
strength. As T-type channels have been suggested to couple Ca
2+





we examined whether T-type Ca
2+
 channel blockers would cause a disruption 
of Ca
2+
 homeostasis at the ER, ultimately leading to the observed apoptosis. To our 
knowledge, no studies have addressed this question previously. A number of articles had 
already been published indicating ER stress as a driver of malignancy in melanoma 
tumors
147
. In our study, we also checked that untreated M16, JG and M28 cells displayed 
some degree of ER stress, which was absent in untransformed  melanocytes. An RT-PCR 
analysis of total RNA, showed a basal level of splicing of the XBP-1 transcription factor 
in untreated melanoma cells, which was absent in untransformed melanocytes (Figure 
26B).GRP78, another marker of UPR is also upregulated in melanoma cells in 
comparison to the untransformed melanocytes (26A). 
 




Figure 26. Melanoma cells express some degree of ER stress which is absent in control normal 
melanocytes. Western blot of total protein lysate of human control melanocytes and melanoma 







control melanocytes (panel A). β actin was used as loading control. RT-PCR analysis of untreated 
melanocytes and melanoma cells (M16, JG, M28) shows upregulation of spliced (s) XBP-1in 
comparison to control normal melanocytes (panel B). Here GAPDH was used as loading control 
and M stands for melanocytes.  
 
In order to evaluate a putative effect of Mibefradil and Pimozide on the ER, the induction 
of GRP78/αBIP, a well-characterized UPR molecular chaperone, was determined in a 
series of time-course experiments. Cells treated with Thapsigargin, a classical inhibitor of 
the SERCA pump, were used as a positive control. Mibefradil and Pimozide induced a 
clear up-regulation of GRP78 in M16 and JG cells treated for 4, 8, 16 and 24 hrs. (Figure 
27 A,B,E,F), remaining stable at all time points.  
 
We further examined which ones out of the three branches of the UPR were activated by 
T-type channel blockers. Activation of ER-resident transmembrane protein and 
transcription factor ATF6 induces the expression of XBP-1 mRNA
135-138
 Another ER-
resident transmembrane protein, IRE1α has an endoribonuclease domain, by which it 
splices a 26 nucleotide fragment out of the XBP-1 mRNA (frame-shift splice variant of 
XBP-1 mRNA) when activated. The generated frame-shift splice variant (sXBP-1) codes 
for a transcription factor that induces the expression of ER chaperones. Mibefradil-treated 
M16 and JG cells showed a robust splicing of XBP-1 at all time points (making a clear 
difference with the sXBP-1 levels present in untreated cells), along a consistent decrease 
of unspliced native XBP-1 (Figure 27 C-D). Pimozide-treated melanoma cells also 
showed an enhanced XBP-1 splicing at 4 and 8 hrs time points. Thus both T-type channel 
blockers induced the activation of the IRE1α pathway of the UPR (Figure 27 G-H).  
 
As mentioned above, during prolonged or severe ER stress the cytoprotective, adaptive 
UPR can switch from a pro-apoptotic response to initiate cell death. Therefore, we 
questioned whether the UPR-mediated apoptotic pathway was taking part in the Ca
2+
 
channel blockers-induced melanoma cell death. The transcription factor 
GADD153/CHOP has been shown to play a central role by altering the balance of pro- 
and anti-apoptotic Bcl-2 proteins, to promote apoptosis
139
. GADD153 levels were 
undetectable in untreated melanocytes or melanoma cells. However, exposure of JG and 







GADD153/CHOP, which was detectable at 4 and 8 hrs during Mibefradil application 




Figure 27. Mibefradil and Pimozide induce ER stress in M16 and JG cells. Western blotting of 
the whole cell lysates of M16 cells and JG cells treated with Mibefradil (panel A and B 
respectively) for 4, 8, 16 and 24 hrs show upregulation of GRP78 and GADD153. Similarly 
Pimozide also induces similar upregulation of GRP78 and GADD153 in M16 (panel E) and JG 
(panel F) cells. β actin was used as loading control for western blot analysis of protein sample. 







upregulation of spliced (s) XBP-1 at 4,8,16 hrs. Pimozide also shows similar upregulation of 
spliced XBP-1 in M16 (panel G) and JG (panel H) cells. In all the experiments cells treated with 
Thapsigargin were used as positive control. For RT-PCR analysis GAPDH was used as loading 
control. 
  
Earlier, we had shown that Kurtoxin induced a decrease in the proliferation of JG cells 
(Figure 16A). To further investigate the effects of Kurtoxin on the ER of melanoma cells, 
we treated JG cells with 250 nM of Kurtoxin for 4, 8, 16 and 24 hrs. Like for Mibefradil 
or Pimozide treatments, we found increased GRP78 protein levels (Figure 28A); the up-
regulation of GRP78 reached a maximum at 8 hrs into the treatment with Kurtoxin, 
followed by a slow decline at 16 and 24 hrs. In addition, we observed the time dependent 
splicing of XBP-1 at all time points (Figure 28 B), indicating that Kurtoxin-induced ER 
stress also involves the IRE1α signalling pathway of UPR, like for Mibefradil or 
Pimozide. In contrast, we detected only a very mild up-regulation of GADD153 after 16 
and 24 hrs. application of Kurtoxin (Figure 28A); this result is consistent with the flow 
cytometry analysis of DNA content of Kurtoxin-treated JG cells, in which no significant 
increase in the percentage of cells in the sub-G1 phase was visible at 24 hours treatments 
(Figure 16A).  
 
Figure 28. Kurtoxin induces endoplasmic reticulum stress in JG cells. Western blot of total 







upregulation of GRP78 without any upregulation of GADD153 expression.ß actin was used as 
loading control.RT PCR analysis of total RNA extract (panel B) shows time dependent 
upregulation of spliced XBP-1 (sXBP-1). Here GAPDH was used as loading control.  
 
Leaving the expression of GADD153 aside, the coincidence of effects of the structurally 
unrelated Mibefradil and Pimozide on the one hand, and the peptide neurotoxin Kurtoxin 
in the other, seemed to point steadily to T-type channels as the real targets of the 
pharmacological blockade-mediated effects in the ER. In an attempt to elucidate a direct 
role for specific T-type channel isoforms, we transfected M16 cells with short interfering 
RNAs (siRNAs) specific for Cav3.1 and Cav3.2 T-type channels, and JG cells with Cav3.2 
siRNA; we monitored the level of channel knockdown by Q-PCR, achieving knock down 
comprised between 79 and 80% (Figure 33E). The attained western blot results showed 
that the silencing of both Cav3.1 and Cav3.2 isoforms associates to the splicing of XBP-1, 
and to the up-regulation of GRP78 and GADD153 proteins, thus mimicking the effects of 
Mibefradil and Pimozide (Figure 33). 
 
5. Melanoma cells display a basal autophagy which is inhibited by T-type channel 
blockers and T-type channels gene silencing 
 
A sustained UPR has been linked to the development of macroautophagy, an adaptative 





Initially, we examined the putative unfolding of an autophagic process in melanoma cells 
by staining them with LysoTracker
®
 Red DND-99 , an acidotropic autofluorescent 
compound which accumulates into acidic compartments like lysosomes and 
autolysosomes and thus can be used as a marker of macroautophagy
244
. The images 
displayed in Figure 31 show that, when M16 and JG melanoma cells were challenged 
with Mibefradil or Pimozide, the number of acidic vesicles (displaying a punctuated 
fluorescence) was dramatically augmented. These results prompted us to examine the 
expression of 2 key mediators of canonical macroautophagy at the protein level, using 
antibodies specific for the inducible genes Beclin1 (Atg6) and Atg5 in Western blot 
assays, in control normal melanocytes and melanoma cells. At the peak of the UPR (8 







significantly, and that did not happen for the whole time course (0-16 h or 0-24 h 
depending on the experiments) (Figure 30). Regarding Atg5, Mibefradil induced a slight 
decrease at the 4 h time point and no further changes (Figure 30A-B), whereas Pimozide 
triggered a mild increase of both Atg5 levels and assembly of the Atg5-Atg12 complex 
(figure 30C-D). 
 
Since these results did not show the induction of a canonical autophagy by the blockers, 
we further analyzed the conversion of LC3 (Atg8) from the soluble form (LC3-I) to the 
autophagosomal-associated lipidated form (LC3-II), which can be taken as an indirect 
measurement of the number of autophagosomes
214
. These data showed that, while in 
melanocytes LC3-II remained undetectable at all times (Figure 29A) in M16 and JG 
melanoma cells LC3-II was increased in a time dependent manner by treatment with 
Mibefradil (Figure 30A-B), Pimozide (Figure 30C-D) and Kurtoxin (Figure 32C). 
Importantly, the untreated controls at 0 time point also showed that the LC3-II/I ratio was 
constitutively increased in M16 cells and JG cells (to a minor extend), compared to 
control melanocytes, in which the LC3-II form was absent. The conversion of LC3-I  to  





Figure 29. Mibefradil and Pimozide induce no endogenous LC3 conversion and autophagosome 
formation in melanocytes. Western blot of total protein lysate of human control melanocytes 







or Beclin 1 (panel A). Here β actin was used as loading control. RT-PCR analysis of melanocytes 
treated with Mibefradil and Pimozide (panel B) show no induction of spliced (s) XBP-1. Here 




Figure 30. Effect of Mibefradil and Pimozide on autophagic flux. Western blot analysis of whole 
cell lysates of M16 cells treated with Mibefradil (Panel A) and Pimozide (Panel C) and JG cells 
treated with Mibefradil (panel B) and Pimozide (panel D) for 4,8,16 hrs show consistent 
upregulation of LC3-II and marked accumulation of p62 without any prominent change in 









Figure 31. Mibefradil and Pimozide induce formation of acidic vesicular organelles in M16 and 
JG cells 6 hrs after the treatment. Melanoma cells were incubated with LysoTracker
®
 Red DND 
99 for two minutes. Cells were washed with phosphate buffer saline and fluorescent micrographs 
were obtained using an inverted fluorescence microscope. Nuclei were counterstained with 
Hoechst 33258 stain. Mibefradil and Pimozide treatment in M16 (panel A) and JG cells (panel B) 
indicate accumulation of acidic vesicles in untreated control cells, which is further increased in 
presense of Mibefradil and Pimozide. 
 
However, it can reflect either an increased or a decreased autophagic flux, according to 
the following paradigm: if the LC3-II/I ratio is further enhanced by addition of a late-
stage inhibitor of macroautophagy, the primary increase  is considered to be the result of 
an increased autophagy; conversely, an elevated LC3-II/I ratio which is not augmented by 
addition of an autophagy inhibitor, is interpreted as the result of a reduced autophagic 
flux and subsequent accumulation of autophagosomes
215
. To distinguish between these 
two possibilities, we applied Mibefradil and Pimozide in M16 (Figure 32A) and JG cells 
(Figure 32B), and Kurtoxin (Figure 32C) in JG cells, in the absence or presence of 
Bafilomycin A1, which is a established inhibitor of autophagosomal-lysosomal fusion. In 
all cases the intensity of the LC3-II band was not further increased by Bafilomycin A1, 








 The p62/SQSTM1 protein facilitates autophagic degradation of ubiquitinated  proteins 
and constitutes one of the best known mammalian autophagy specific substrates
165-167
. As 
p62 degrades upon autophagy stimulation and accumulates when autophagy is inhibited, 
the p62 levels can also be used as markers of autophagic flux. Consistent to LC3-I to 
LC3-II conversion in presense or in absence of Bafilomycin A1, the examination of the 
p62 protein by Western Blott revealed a significant increase of the p62 at 4, 8 and 16 




Figure 32. T-type calcium channel blockers induce autophagy inhibition in human melanoma 
cell. Western blot of total protein lysate of M16 cells treated with Mibefradil and Pimozide (panel 
A) for 6 hrs show accumulation of LC3-II which was not further increased in presence of 
Bafilomycin A1, an inhibitor of autophagosome lysosome fusion indicating that increase in LC3-
II was not due to increased degradation of autophagosomes but due to augmented formation of 
autophagosomes. Western blott JG cells treated with Mibefradil, Pimozide (panel B) for 6 hrs and 











Figure 33. Knock down of Cav3.1 and Cav3.2 induces endoplasmic reticulum stress and 







transfected with siRNA for Cav 3.2 shows upregulation of GRP78, GADD153 and accumulation of 
LC3-II and p62 indicating ER stress and autophagy inhibition simultaneously (panel B). Cells 
transfected with non-specific control siRNA were used as negative control. β actin was used as 
loading control. RT-PCR analysis shows induced splicing of XBP-1 in JG cells transfected with 
siRNA for Cav3.2 (panel A). Here GAPDH was used as loading control. Knock down of Cav3.1 
and Cav3.2 induces similar effect in M16 cells (panel C, D). Q-RT PCR analysis of M16 and JG 
cells transfected with siRNA for Cav3.1 and Cav3.2 shows around 79-80 % decrease in expression 
of the above said isoforms of T-type calcium channels (panel E).      
 
Finally, we investigated a likely causative link between ER stress and autophagy 
inhibition with the use of Salubrinal, a small molecule that protects cells from ER stress 
induced apoptosis by selectively activating the eIF2α branch of the UPR pathway
233
. In 
JG cells treated with Mibefradil and Pimozide, the co-application of Salubrinal 
significantly reduced the expression of LC3-II at the 6 hrs time point, suggesting that the 
PERK-eIF2α signalling pathway of the UPR is determinant for the accumulation of 
autophagosomes in melanoma cells treated with T-type channel blockers (Figure 34). 




Figure 34. PERK-eIF2α signalling pathway of ER stress plays an important role in accumulation 
of autophagosomes in JG human melanoma cells. Western blot of whole cell lysate of JG cells 
treated with Mibefradil and Pimozide for 6 hrs show accumulation of LC3-II which was 
decreased in presense of Salubrinal, an inhibitor of eIF2α dephosphorylation. Here β actin was 








Analogously to the preceding section, we aimed to identify the molecular targets of the 
drug-mediated autophagy inhibition by gene silencing of the specific T-type channel 
isoforms expressed in M16 and JG melanoma cells. The effects of knockdown of Cav3.1 
and Cav3.2 on melanoma cell autophagy were investigated by Western blot analysis of 
LC3 and p62 proteins. In M16 cells, both the knockdown of Cav3.1 and Cav3.2 channels 
rendered an increase of the LC3-II/I ratio and a parallel increase of the p62 band intensity 
(Figure 33d). In JG cells, the knockdown of Cav3.2 channels induced a similar LC3-I/II 
conversion and  p62  accumulation effect (Figure 33b). Thus, the knockdown of either T-
type channel isoform mimicked the Mibefradil/Pimozide/Kurtoxin-mediated inhibition of 
the basal autophagy present in melanoma cells, suggesting that T-type channel 
pharmacological blockers exert its effects on melanoma autophagy by targeting these two 




























































































VGCCs are expressed in different tumours and the role they play in cancer progression is 
a lively field of research. In the present study we have performed a comprehensive 
analysis of the expression of the different VGCC families in a variety of melanoma 
tumours and cell lines. We have found that human melanoma cells express VGCCs from 
three different families: (i) high voltage-activated L-type channels, which require 
significant depolarization to open and thus are widely distributed in excitable tissues; (ii) 
high voltage-activated N-type, P-Q type and R-type channels, classically involved in 
neurotransmitter and hormone release; and (iii) low voltage-activated T-type channels, 
which can operate at potentials near the typical membrane potentials of most cells. 
1. Expression of L-type channels 
Our results show that transcripts for Cav1.2 were undetectable in control normal 
melanocytes and strongly expressed in all melanoma cells except for JG and M17 skin 
metastasis (Figure 8). In contrast, the Cav1.3 isoform was ubiquitously expressed in 
control normal melanocytes and all melanoma cells. It should be taken into account that 
L-type channels are functionally diverse. Whereas Cav1.2 channels are characterized by a 
high threshold and slow kinetics of activation, Cav1.3 channels have been shown to be 
mid threshold activating and to display faster activation kinetics
216, 217
. These properties 
would enable Cav1.3 channels to operate at voltages near the resting membrane potential, 
mediating oscillatory Ca
2+
 entry along with T-type channels. Even though the viability 
assays presented in Figure 19 are not suggestive of a principal role for L-type channels in 
proliferation or survival, it should be taken into account that dihydropyridine actions are 
channel state-dependent
218
, and that Cav1.3 are less sensitive than other L-type channels 
to dihydropyridines
216
. These considerations, together with the lack of Cav1.2 expression 
in untransformed melanocytes and the up-regulation of Cav1.2 channels by hypoxia in JG 
melanoma cells, encourage further investigation of the role of L-type channels in the 
melanoma cell physiology. 
2. Expression of N-type, P-Q type and R-type channels 
Experimental evidence shows that melanocytes display a variety of neuroendocrine 
functions and release neurotransmitters, neuropeptides and hormones, and this production 
is stimulated by ultraviolet radiation and different biological factors
219
. On the other hand, 







particularly in the chromaffin and pheochromocytoma neurosecretory cells
220
. Our results 
show that both control normal melanocytes and melanoma cells (primary tumours and 
metastasis) express Cav2 channels, although the expression profile of the individual 
isoforms is variable (Figure 8). As for Cav1 channels, data from the viability assays rules 
out a direct participation of Cav2 channels in cell cycle regulation. However, the ability to 
correlate qualitative or quantitative changes in Cav2 expression with the neuroendocrine 
activity of tumours may shed light on how melanocyte transformation may be 
accompanied by neuroendocrine differentiation
221
. 
3. Expression of T-type channels 
Our finding regarding the up-regulation of T-type channels in melanoma cells was 





The relevance of T-type channel expression in melanoma cells is 
highlighted by the fact that Cav3 isoforms may be selectively up-regulated in moderate 
hypoxic conditions (Figure 10) which approach the real hypoxic environment of skin and 
the high oxygen demand in metastasis. The effect of Kurtoxin in reducing the percentage 
of proliferating melanoma cells (Figure 16A) further suggests a relevant role for Cav3.1 
and Cav3.2 channels in cell cycle control
97
. Nonetheless, the stronger effect of Kurtoxin 
on the viability of melanoma cells as measured by a colorimetric assay (Figure 19) also 
suggests that these T-type channels play an additional role in cell homeostasis 
maintenance. In line with this, it has been shown that T-type channel blockers are 





-imaging experiments displays in Figure 15 indicate that cultured melanoma 
cells display a basal Ca
2+
 influx which can be reduced by Mibefradil. This result is 
consistent with the occurrence of T-type channel window currents, providing the pattern 
of Ca
2+
 signalling required for cell cycle progression. Ca
2+
 transients are evident during 
certain stages of mitotic progression and these signals are transduced principally by direct 
binding of Ca
2+
 to intracellular receptors such as calmodulin
225
. A few models have been 
put forward to explain the role of T-type channels in promoting transient elevations of 
cytosolic Ca
2+





The precise signalling mechanisms for specific T-type channel subunits remain 
unknown
69







and the other Cav3 channels (Figure 8) and the linkage between Cav3.1 expression and a 
low proliferation rate (Table 9) is intriguing. On one hand, we have shown that melanoma 
JG or M28 cells (expressing mainly Cav3.2 channels in normoxia) display a faster 
proliferation rate compared with Cav3.1-expressing M16 cells (Figure 11). Furthermore, 
other cell lines expressing Cav3.1 channels are either average-proliferating (M17) or slow 
proliferating (M9 and M29) (Table 9). On the other hand, the siRNA experiments show a 
direct involvement of both Cav3.1 and Cav3.2 isoforms in the proliferation of M16 and JG 
cells, respectively, as the percentage of cells in the S phase is decreased upon silencing of 
either gene (Figure 16B-C). Importantly, hypoxia experiments point in the same direction. 
In JG cells, in which both Cav3.1 and Cav3.2 are up-regulated by low O2, the percentage 
of cells in the S phase is increased. In contrast, M16 cells under hypoxia experience a 
down-regulation of both Cav3.1 and Cav3.2 T-type channels and consequently are arrested 
at the G1 and S phases (Figure 17). The reversal of hypoxic effects on cell proliferation 
by Cav3.1 and Cav3.2 gene silencing (Figure 18B), further confirms the pivotal role of 
these T-type channels in the control of the cell cycle. Altogether, our data suggest that, 
whereas both Cav3.1 and Cav3.2 channels promote the progression of the melanoma cell 
cycle, Cav3.1 channels associate to slow cycling and are induced in environmentally 
stressful conditions. 
4. Dual effect of T-type channel pharmacological blockers on melanoma cells 
viability: decreased cell proliferation and increased apoptosis 
Up to this point we had found that the knockdown of Cav3.1 and Cav3.2 T-type channels 
slows down the progression of the melanoma cell cycle and that Kurtoxin, the most 
specific T-type channel blocker available up to date, also decreases the viability of 
melanoma cells by affecting the proliferating rate. The results encouraged us to check the 
effect of clinically used, well known T-type channel blockers such as Mibefradil and 
Pimozide, on human melanoma cells. For that purpose and, in an attempt to achieve some 
conclusions regarding the T-type channel isoforms involved in the pharmacological 
blockade effects, we selected out 2 metastatic cell lines showing a differential pattern of 
T-type channels expression: while JG cells only expressed the Cav3.2 isoform, M16 cells 
additionally expressed the Cav3.1 isoform. We had earlier shown that the expression of 
Cav3.1 is low or undetectable in fast-growing metastatic melanoma cell lines where 







treatments, both Mibefradil and Pimozide affected cellular viability and that, for the fast-
growing melanoma cell lines (JG, M28, M36), the EC50 value was lower in comparison to 
EC50 value for slow-growing cell lines from primary tumors (M9) or metastatic 
melanoma (M29, M17 or JG). These data suggests that the effect of both drugs is 
proliferation state-dependent.  
The PI/FACS (cell cycle) analysis revealed that Mibefradil and Pimozide not only 
affected melanoma cells proliferation, but that they also induced a powerful apoptotic 
process, that was cross-checked by Hoechst staining and caspase 3 and 9 activation 
assays. This dual aspect of clinical T-type channel blockers immediately raise the 
question of why the effects on cell death were not seen by application of Kurtoxin. We 
can provide two possible explanations: (1) T-type channel blockade by 10 M Mibefradil 
or Pimozide would be more effective than T-type channel blockade by 250 nM Kurtoxin. 
Although Chuang et al. (1998)
97
 reported a nearly 95% blockade of Cav3.1 and an 85% 
blockade of Cav3.2 at 350 nM Kurtoxin (expressing recombinant channels in Xenopus 
oocytes), they found that the blockade was strongly voltage-dependent. In comparison, 
data available for Mibefradil and Pimozide, with EC50 values for T-type channels 
blockade in the high nM range
234, 235
, suggest that at the applied 10 M concentration, the 
blockade would be complete for the 3 T-type channel isoforms. (2) Numerous 
“unspecific” effects other than T-type channels blockade have been reported for 
Mibefradil and Pimozide, including L-type and N-type Ca
2+










5. T-type calcium channel blockers induce ER stress and non-adaptive UPR in 
melanoma cells 
 
Regardless of the identity of the molecular targets for the structurally unrelated 
Mibefradil and Pimozide we had decided to investigate the pathways leading to apoptosis 
of melanoma cells. 
 
Endoplasmic reticulum (ER) stress and subsequent unfolded protein response (UPR) are 
primarily an adaptive response, aiming to restore ER homeostasis and protect the cell 
from the accumulation of unfolded or misfolded proteins. There are ample evidences that 







development. Several of the metabolic consequences of ER stress, such as increased 
glycolysis and high lactic acid dehydrogenase (LDH), are readily apparent in patients 
with melanoma. Indeed, LDH levels in sera are the single most powerful predictor of 
prognosis in metastatic disease
238
. As discussed by others, adaptation to ER stress may be 
a key driver of malignancy and resistance to therapy
239
. There are also evidences of 
constitutive activation of the UPR in cultured melanoma even in the absence of additional 
ER stress induction
142
. Our results also show that there is a certain level of splicing of 
XBP-1 in melanoma cells in comparison to melanocytes (Figure 26B) and an 
upregulation of GRP78 in melanoma cells in comparison to the melanocytes (figure 26A). 
A sustained UPR has been linked to autophagy induction, a survival response dealing 
with the degradation of protein aggregates
144
. Nonetheless, if the stress is such that 
overwhelms the adaptive response, the UPR may convey into apoptosis
212
. For these 
reasons, both the pharmacological inhibition and induction of UPR have been 




Previously Bertolesi et. al. (2002) had found a correlation between T-type current 
blockade and cell death (by either apoptosis or necrosis) produced by Mibefradil and 
Pimozide in retinoblastoma Y79 cells and adrenocarcinoma MCF7 epithelial cells
82
, 
although no specific pathways were examined. In our study we have found, for the first 
time in any cell type, that the three T-type channel blockers Mibefradil, Pimozide and 
Kurtoxin induce splicing of XBP-1 (sXBP-1) (Figure 27 and 28), a marker for the 
coordinated action of active ATF6 and IRE1α. The early appearance of sXBP-1 mRNA 
during the first 4 hrs of treatment with Mibefradil and Pimozide, and the level of the 
splicing, were comparable to those induced by Thapsigargin, a classical inducer of ER 
stress. The up-regulation of GRP78 and GADD153/CHOP were also prominent in the 
early hours of treatment with Mibefradil and Pimozide. In the light of the data obtained 
from viability and apoptotic assays at 24 h treatments, these results emphasize that 
Mibefradil and Pimozide induce a pro-apoptotic branch of the ER stress pathway. The 
regulation of this effect may be via induction of the pro-apoptotic transcription factor 
GADD153 and subsequent activation of the ER-localized caspase-12; the activated ER 
stress death pathway, in concert with the mitochondrial death pathway, would trigger the 
so called intrinsic pathway of caspase activation (including the observed cleavage of 
caspases 9 and 3) (Figure 25), cytoskeleton breakdown and nuclear fragmentation, 







Mibefradil and Pimozide-treated cells, also suggests that PERK-mediated eIF2α 
phosphorylation and transcriptional activation of ATF4 may be triggered, since this 
signalling pathway plays a dominant role in the induction of GADD153
241, 242
. In this 
regard, it has been shown that induction of ATF4 and GADD153 by ER stress is nearly 
completely attenuated in PERK null cells and eIF2α
S51A
 cells (containing a mutation at 




Previous studies have claimed that the mammalian UPR is linked to the inhibition Cyclin 
D1 translation and of cell cycle progression
226
. This was also the case for Mibefradil and 
Pimozide effects in our study (Figure 23). 
 
6. The knockdown of Cav3.1 and Cav3.2 channels mimics the effects of T-type 
channel pharmacological blockade    
 
Our experiments show that the siRNA-mediated gene silencing of Cav3.2 channels in JG 
cells and Cav3.1 or Cav3.2 channels in M16 cells also leads to the up-regulation of GRP78 
and GADD153 and to the splicing of XBP-1 (Figure 33). These results unveil a more 
specific link between Cav3.1/Cav3.2 isoforms of T-type calcium channel and ER calcium 
homeostasis, resulting in the activation of the IRE1α pathway. In line with this, we have 
recorded in M16 cells oscillations in the intracellular calcium levels which were reduced 
by Mibefradil, indicating a crosstalk between cytoplasmic and ER Ca
2+
 levels (Figure 14). 
However, the application of Kurtoxin induced only minor up-regulation of pro-apoptotic 
GADD153 (Figure 28) and, consistently, melanoma cells did not undergo an apoptotic 
process in the presence of this neurotoxin at 24 h treatments. Given the fact that Cav3.1 
and Cav3.2 knockdown up-regulated GADD153 in melanoma cells (albeit apoptosis was 
not assessed), we believe that it is likely that Kurtoxin (at 250 nM) induces only a partial 
blockade of Cav3.1 and Cav3.2 in the tested melanoma cells, as pointed out in the 
preceding section. 
 
7. T-type calcium channels blockade or gene silencing inhibits the constitutive 
autophagy present in melanoma cells  
 
There are emerging evidences supporting the idea that the ER status plays an important 







autophagy is critical for maintaining ER homeostasis
245-247
. Recent articles indicate that 
the IRE1α-JNK pathway and the PERK or ATF6 pathway are required for autophagy 
activation after ER stress 
143-147
. In addition, it has been reported that basal autophagy 





Since we had found a high level of sXBP-1 in untreated melanoma cells in 
comparison to control normal melanocytes (Figure 26B) and an upregulation of GRP78 
(26A) we were suspicious about the presence of basal autophagy in melanoma cells. 
Consistently, the detection of the autophagosomal-associated LC3-II protein, which was 
further enhanced by co-application of Bafilomycin A1, demonstrated that M16 and JG 
were displaying a significant (albeit different) activation of macroautophagy (Figure 32), 
contrarily to control melanocytes (Figure 29A). In addition, a basal level of 
macroautophagy in melanoma cells could be seen by the presence of a high number of 
acidic vacuoles stained with LysoTracker
®
 Red DND-99 (Figure 31). 
 
As pointed above, upon sustained ER stress-stimuli the UPR may trigger a 
macroautophagic process. However, the apoptotic death induced by Mibefradil and 
Pimozide was difficult to reconcile with the activation of autophagy, which is an adaptive 
response by nature. Initially, we addressed this issue by using the same tools that had 
uncovered the presence of basal autophagy (Figure 32). To our surprise, these results 
initially seemed to show that the T-type channel blockers were enhancing the autophagy 
in M16 and JG melanoma cells, as they were inducing a prominent increase of the LC3-II 
form, in parallel to an increase in the labelling of acidic compartments by LR, indicative 
of the accumulation of autophagic vacuoles (AV). However, an increased number of AV 
is not always the consequence of an enhanced autophagy, but may also result from the 
failed elimination of autophagic debris, that is, from the blockade of the autophagic flow. 
When we monitored the level of autophagic substrate p62/SQSTM1 (Figure 30) and we 
additionally applied the Mizushima paradigm for LC3-I-II conversion in the presence of 
Bafilomycin A1 (Figure 32), it became clear that T-type channel blockers were inhibiting, 
rather than enhancing, the constitutive autophagy of melanoma cells. Because of the 
obvious accumulation of AVs such inhibition must occur at a late stage of the 
macroautophagic process, by preventing the fusion of autophagosomes with lysosomes. 
Importantly, not only Kurtoxin was able to mimic the effects of Mibefradil and Pimozide 
regarding LC3-I-II conversion in the presence of Bafilomycin A1 (Figure 32), but the 







on LC3-I-II conversion and p62 increased levels (Figure 33), reassuring that the blockade 
of autophagic flow by T-type channel blockers was targeting T-type channels and, 
particularly, the Cav3.1 and Cav3.2 isoforms.  
 
Our results also show the activation of the pro-apoptotic UPR branch in response to T-
type channel blocker-mediated ER-stress, and that this is linked to autophagosome 
accumulation, and not to their biogenesis. During ER stress, eIF2α phosphorylation by 
PERK reduces protein synthesis and alleviates cell from death
232
. Here, we demonstrate 
that Salubrinal, a selective inhibitor of the eIF2α dephosphorylation
233
, reduces LC3-I-II 
conversion during Mibefradil or Pimozide treatment (Figure 34). On a first glance, these 
results would appear conflicting with the known role of eIF2α phosphorylation in 
inducing autophagy. One can speculate that both the magnitude and duration of eIF2α 
phosphorylation might be important factors in adjusting the autophagic response to ER 
stress. However, we rather take the results using Salubrinal as a further proof that the LC3 
I-II conversion in the presence of T-type channel blockers is a reflex of autophagy 
inhibition, rather than autophagy induction. Importantly, this result also allows establish a 
chronological sequence of events, by virtue of which ER stress anticipates autophagy 
inhibition, and it is the likely cause of it.    
 
Indeed, our study demonstrates that the T-type channel blockade-mediated melanoma cell 
death associated to the accumulation of AVs is the result of inhibited, rather than 
exacerbated autophagy. T-type channels blockade apparently inhibit the formation of 
autophagolysosomes through the fusion of AV and lysosomes, thereby reducing the 
turnover of AV. Although autophagic vacuolization by itself is not lethal, it primes cells 
for death accompanied by a loss in the mitochondrial membrane potential, relocation of 
cytochrome C from mitochondria to the cytosol and activation of Caspases
151, 199, 174
. We 
have checked how a disabled autophagy in melanoma cells is linked to cell death via the 
up-regulation of the pro-apoptotic UPR branch and a common final pathway involving 
biochemical features of apoptosis. Irrespective of the detailed molecular pathways linking 
disabled autophagy to mitochondrial apoptosis, the results attained in this work add to the 









Recent studies have demonstrated that inhibition of macroautophagy induces apoptosis in 
cancer cells 
182-186
. Conversely, inhibition of apoptosis also induces macroautophagy in a 
reciprocal manner
173-176
. Moreover, many currently used chemotherapeutical agents 
induce the proliferation of autophagosomes in vitro, which is likely to represent a 
protective mechanism of cancer cells against the stress induced by cytotoxic agents. 
Conversely, inhibition of autophagy by various lysosomotropic agents has been shown to 
sensitize tumour cells to chemotherapy
180, 182, 184-189
. These findings suggest that apoptosis 
and macroautophagy are two complementary reciprocally regulated pathways for 
regulating the cell fate between death and survival. Targeting the autophagy regulation of 
cancer cells is a therapeutic strategy yet to be properly designed and, in fact, it is 
becoming obvious that such approaches will need to be tailored for every kind of tumour 
and stage of tumorigenesis.  
 
Melanoma incidence has increased in last four decades and diverse therapies targeting 
specific molecules involved in melanoma progression are under evaluation 
228, 229, 230
. The 
involvement of pathophysiological Ca
2+
 signalling in cancer promises new therapeutic 
strategies. There are a growing number of publications describing the expression of Ca
2+
 
channel types in cancer, and the functional consequences of channel blockade on tumour 
parameters such as growth, migration or invasion. In this Thesis we present seminal data 
demonstrating the expression of a wide range of VGCCs in melanoma cells and the 
involvement of T-type channels in cell cycle control. We also show that human 
melanoma cells experience basal levels of adaptive UPR and macroautophagy, and that 
T-type channel blockers induce a caspase-dependent melanoma cell death through a 
sustained ER-stress and subsequent inhibition of the constitutive macroautophagy present 
in these cells. Finally, we identify T-type Cav3.1 and Cav3.2 channels as the targets for 
clinically used T-type channel blockers, by a gene silencing approach. Thus, our findings 
provide putative markers of melanoma progression, and the rationale for possible 
pharmacological therapies using T-type channel blockers, alone or in combination 
























































































1. Human melanoma cells and normal melanocytes express a diversity of voltage-
gated calcium channels, including members of the Cav1 family (L-type) and Cav2 
family (N-type, P/Q-type and R-type). Importantly, the expression of Cav3 family 
members (T-type) is detectable only in melanoma cells, in which mediates a 
constitutive influx of divalent cations in the absence of membrane depolarization, 
but not in normal untransformed melanocytes. 
 
2. The expression of the Cav3.1 and Cav3.2 isoforms of T-type channels is mutually 
exclusive to a certain extent. Cav3.1 channels are prominently expressed in 
melanoma cell lines displaying a low or average proliferation rate, whereas Cav3.2 
channels are the main T-type channel isoform in melanoma cell lines displaying a 
fast proliferation rate. 
 
3. Both T-type Cav3.1 and Cav3.2 channels are involved in the melanoma cell cycle 
progression. Gene silencing of either isoform results in a significant degree of cell 
cycle arrest, as evidenced by increased percentage of cells at the G1 phase and 
decreased percentage of cells at the S-phase. 
 
4. Moderate hypoxia (1% O2) may induce the selective up-regulation of the T-type 
Cav3.1 isoform and, to a lesser extent, of the Cav3.2 isoform. These effects are 
dependent on the melanoma cell type. The hypoxia-mediated up-regulation of T-
type channels is associated with an increased proliferation rate of the involved 
melanoma cell lines. 
 
5. The application of the T-type channel blocker Kurtoxin, affects melanoma viability 
in a negative way, by promoting cell cycle arrest. In contrast, synthetic T-type 
channel pharmacological blockers with a therapeutic pedigree in cardiovascular 
and nervous system diseases, Mibefradil and Pimozide respectively, affect 
negatively the viability of melanoma cells at two levels: (1) by promoting cell 
cycle arrest;  and  (2) by inducing the intrinsic apoptosis pathway. 
 
6. The melanoma cell death process triggered by T-type channel blockers Mibefradil 







associated unfolded protein response, followed by inhibition of the constitutive 
autophagy present in these cells. 
 
7. The knockdown of T-type Cav3.1 and Cav3.2 channels in melanoma cells also 
induces the unfolded protein response, and inhibits the constitutive autophagy. 
Thus, these T-type channel subtypes are the likely targets of T-type channel 
blockers, regarding the reported effects on melanoma cells homeostasis and 


































Das A, Pushparaj C, Bahí N, Sorolla A, Herreros J, Pamplona R, Vilella R, Matias-Guiu 
X, Martí RM, Cantí C (2012) Functional expression of voltage-gated calcium channels in 









































































































1. Clark WH, Jr., Tucker MA and Goldstein AM (1995) Parenchymal-stromal 
interactions in neoplasia.Theoretical considerations and observations in 
melanocytic neoplasia. Acta.Oncol. 34(6): 749-7571 
 
2. Kaddu S, Smolle J, Zenahlik P, Hofmann-Wellenhof R, Kerl H.(2002) Melanoma 
with benign melanocytic naevus components: reappraisal of clinicopathological 
features and prognosis. Melanoma Res 12(3): 271-278 
 
3. Weatherhead SC, Haniffa M and Lawrence CM (2007) Melanomas arising from 
naevi and de novo melanomas--does origin matter? Br J Dermatol 156(1): 72-76 
 
4. Yovino J (2005) Thaller S Potential for development of malignant melanoma 
with congenital melanocytic nevi. J Craniofac Surg 16(5): 871-873 
 
5. Jen M, Murphy M, Grant-Kels JM Childhood melanoma (2009) Clin Dermatol 
27(6): 529-536 
 
6. Yakov Chudnovsky, Paul A. Khavari, and Amy E. Adams (2005) Melanoma 
genetics and the development of rational therapeutics The Journal of Clinical 
Investigation 115 (4) (813-824) 
 
7. Thompson JF, Scolyer RA, Kefford RF (2005) Cutaneous melanoma. Lancet 365 
(9460): 687-701 
 
8. Breslow A (1970) Thickness, cross-sectional areas and depth of invasion in the 
prognosis of cutaneous melanoma. Ann Surg 172(5): 902-908 
 
9. Clark WH, Jr., From L, Bernardino EA, Mihm MC (1969) The histogenesis and 
biologic behavior of primary human malignant melanomas of the skin. Cancer 
Res 29(3): 705-727 
 








11. Rigel DS, Carucci JA (2000) Malignant melanoma: prevention, early detection, 
and treatment in the 21st century. CA Cancer J Clin 50(4): 215-236; quiz 237-
240 
 
12. Vanessa Gray Schopfer, Claudia Wellbrock, Richard Marais (2007) Melanoma 
biology and new targeted therapy. Nature 445, 851-857 
 
13. Jennings L, Murphy GM (2000) Predicting outcome in melanoma: where are we 
now?  Br J Dermatol 161(3): 496-503 
 
14. Gogas H, Eggermont AM, Hauschild A, Hersey P, Mohr P, Schadendorf D, 
Spatz A, Dummer R (2009) Biomarkers in melanoma. Ann Oncol 20 Suppl 6: 
vi8-13 
 
15. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics CA 
Cancer J Clin 2009; 59(4): 225-249 
 
16. Marrett LD, King WD, Walter SD (1992) Use of host factors to identify people at 
high risk for cutaneous malignant melanoma CMAJ 147 (4): 445-453 
 
17. Claus Garbe, Ulrike Leiter (2009) Melanoma epidemiology and trends Clinics in 
Dermatology 27, 3-9  
 
18. Cox J.L, Lancaster T and Carlson C.G. (2002) Changes in the motility of B16F10 
melanoma cells induced by alterations in resting calcium influx. Melanoma Res. 
12, 211–219. 
 
19. Deli T, Varga N, Adam A et al.(2007) Functional genomics of calcium channels 
in human melanoma cells. Int. J. Cancer 121, 55–65. 
 
20. Glass-Marmor L, Penso J, and Beitner R (1992) Ca2+ induced changes in energy 








21. Oka M, Kikkawa U. (2005) Protein kinase C in melanoma.Cancer Metast Rev 
24:287–300. 
 
22. Demaurex N, Distelhorst C (2003) Apoptosis—the calcium connection. Science 
300 :65-67 
 
23. Allen DH, Lepple-Wienhues A, Cahalan MD (1997) Ion channel phenotype of 
melanoma cell lines. J Membr Biol 155:27–34. 
 
24. MJ Berridge, MD Bootman, P Lipp (1998) Calcium—a life and death signal, 
Nature 395; 645–648. 
 
25. MJ Berridge, P Lipp, MD Bootman (2000) The versatility and universality of 
calcium signalling, Nat. Rev. Mol. Cell Biol. 1;11–21. 
 
26. M.J.Berridge, M.D. Bootman, H.L. Roderick (2003) Calcium signalling: 
dynamics, homeostasis and remodelling, Nat. Rev. Mol. Cell Biol. 4 517–529. 
 
27. Michiaki Yamakage, Akiyoshi Namiki (2001) Calcium channels-basic aspects of 
their structure, function and gene encoding; anesthetic action on the channels - a 
review. Can J Anesth. 49: 2 (151–164) 
 
28. Dolphin AC (2006) A short history of voltage-gated calcium channels. Br J 
Pharmacol.147 (Suppl 1): S56–S62. 
 
29. Catterall WA (2000) Structure and regulation of voltage-gated Ca2+ channels. 
Annu .Rev. Cell Dev. Biol. 2000 16, 521–555 
 
30. Bito H, Deisseroth, K & Tsien, RW (1997) Ca2+ dependent regulation in neuronal 
gene expression. Curr. Opin. Neurobiol; 419–429. 
 









32. Spitzer NC, Gu X & Olson E (1994) Action potentials, calcium transients and the 
control of differentiation of excitable cells. Curr.Opin.Neurobiol.,4,70–77. 
 
33. Marshall J., Dolan B.M., Garcia E.P., Sathe S., Tang X., Mao Z. & Blair L. A. 
(2003) Calcium channel and NMDA receptor activities differentially regulate 
nuclear C ⁄ EBPb levels to control neuronal survival. Neuron, 39, 625–639. 
 
34. Nicotera P. & Orrenius S. (1998) The role of calcium in apoptosis. Cell Calcium, 
23, 173–180. 
 
35. Weick JP, Groth RD, Isaksen AL & Mermelstein PG (2003) Interaction with 
PDZ proteins are required for L-type calcium channels to activate cAMP 
response element-binding protein-dependent gene expression.J. Neurosci., 23, 
3446–3456. 
 
36. Toescu EC, Verkhratsky A & Landfield PW (2004) Ca2+ regulation and gene 
expression in normal brain aging. Trends Neurosci., 27, 614–620. 
 
37. Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME (2001) Signaling to 
the nucleus by an L-type calcium channel-calmodulin complex through the MAP 
kinase pathway. Science 294:333–339. 
 
38. C R Kahl, A R Means (2003) Regulation of cell cycle progression by calcium / 
calmodulin - dependent pathways, Endocr. Rev. 24 719–736. 
 
39. MJ Berridge (1995) Calcium signaling and cell proliferation, Bioessays 17 491–
500. 
 
40. Richard S, Neveu D, Carnac G, Bodin P, Travo P, Nargeot J (1992) Differential 
expression of voltage-gated Ca
2+ 
currents in cultivated aortic myocytes. Biochem 









41. Guo W, Kamiya K, Kodama I, Toyama J. (1998) Cell cycle-related changes in 
the voltage-gated Ca
2+
 currents in cultured newborn rat ventricular myocytes. J 
Mol Cell Cardiol. 30(6):1095-103. 
 
42. Kuga T, Kobayashi S, Hirakawa Y, Kanaide H, Takeshita A (1996) Cell cycle--
dependent expression of L- and T-type Ca
2+
 currents in rat aortic smooth muscle 
cells in primary culture. Circ Res. 79(1):14-9. 
 
43. Panner, A, Cribbs LL, Zainelli GM, Origitano TC, Singh, S, Wurster RD (2005) 
Variation of T-type calcium channel protein expression affects cell division of 
cultured tumor cells. Cell Calcium 37:105–119. 
 
44. DM Rodman, K Reese, JL Cribbs et.al. (2005) Low voltage- activated (T-type) 
calcium channels control proliferation of human pulmonary artery myocytes, 
Circ. Res. 96 864–872 
 
45. N Akaike, H Kanaide, T Kuga, M Nakamura, J Sadoshima, H Tomoike (1989) 
Low-voltage-activated calcium current in rat aorta smooth muscle cells in 
primary culture, J. Physiol. 416 (1989) 141–160. 
 
46. PA Boyden, CD Jack (1995) Ion channel function in disease, Cardiovasc.Res. 29. 
312–318. 
 
47. Marino AA et. al. (1994) Association between cell membrane potential and 
breast cancer. Tumour Biol. 15, 82–89 
 
48. Prevarskaya N, Skryma R, Shuba Y (2010) Ion channels and the hallmarks of 
cancer. Trends Mol Med; 16:107–121 
 
49. Zhang, WM. et. al. (2008) Endothelin-1 enhances proliferation of lung cancer 
cells by increasing intracellular free Ca
2+ 
Life Sci. 82, 764–771 
 
50. Brereton HM, Harland ML, Froscio M., Petronijevic T, Barritt GJ (1997) Novel 







liver-derived cell line: deletion in the IVS4 voltage sensing region. Cell Calcium 
22, 39–52. 
 
51. Li Y et al. (2007) FSH stimulates ovarian cancer cell growth by action on growth 
factor variant receptor. Mol. Cell Endocrinol. 267, 26–37 
 
52. Yukihiro S, Posner GH, Guggino SE (1994) Vitamin D3 analogs stimulate 
calcium currents in rat osteosarcoma cells. J Biol Chem 269:23889–23893 
 
53. Barry ELR, Gesek FA, Froehner SC, Friedman PA (1995) Multiple calcium 
channel transcriptions in rat osteosarcoma cells: selective activation of a1D 
isoform by parathyroid hormone. Proc Natl Acad Sci USA 92:10914–10918 
 
54. Leipziger J, Fisher KG, Greger R (1994) Voltage-dependent Ca2+ influx in the 
epithelial cell line HT29: simultaneous use of intracellular Ca
2+
 measurements 
and nystatin perforated patch-clamp technique.Pflugers Arch 426:427–432 
 
55. Bou-Hanna C, Berthon B, Combettes L, Claret M, Laboisse CL (1994) Role of 
calcium in carbachol- and neurotensin-induced mucin exocytosis in a human 
colonic goblet cell line and cross-talk with the cyclic AMP pathway. Biochem J 
299(Suppl 2):S579–S585 
 
56. Reinlib L, Mikkelsen R, Zahniser D, Dharmsathaphorn K, Donowitz M (1989) 
Carbachol-induced cytosolic free Ca
2+
 increases in T84 colonic cells seen by 
microfluorimetry. Am J Physiol 257:G950– G960 
 
57. Wang XT, Nagaba Y, Cross HS, Wrba F, Zhang L and Guggino SE (2000) The 
mRNA of L-type calcium channel elevated in colon cancer: protein distribution 
in normal and cancerous colon. Am. J. Pathol. 157, 1549–1562. 
 
58. Khazaie K, Schirrmacher V, Lichtner RB (1993) EGF receptor in neoplasia and 
metastasis. Cancer Metastasis12:255–274 
 







60. Maa M-C, Leu T-H, McCarley DJ, Schatzman RC, Parsons SJ (1995) 
Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: 
implications for the etiology of multiple human cancers. Proc Natl Acad Sci USA 
92:6981–6985 
 
61. Hu XQ, Singh N, Mukhopadhyay D, Akbarali HI (1998) Modulation of voltage 
dependent Ca
2+
 channels in rabbit colonic smooth muscle cells by c-Src and focal 
adhesion kinase. J Biol Chem 273:5337–5342 
 
62. Grassi C, D’Ascenzo M, Torsello A, Martinotti G, Wolf F, Cittadini A & Azzena 
GB (2004) Effects of 50 Hz electromagnetic fields on voltage gated Ca2+ 
channels and their role in modulation of neuroendocrine cell proliferation and 
death. Cell Calcium, 35, 307–315. 
 
63. Green ME, Barrett FC, Bultynck G, Shamah SM, Dolmetsch RE (2007) The 
Tumor Suppressor eIF3e Mediates Calcium-Dependent Internalization of the L-
Type Calcium Channel CaV1.2; Neuron 55(4): 615–632. 
 
64. Zhang, L et. al. (1997) Gene expression profiles in normal and cancer cells. 
Science 276, 1268–1272 
 
65. Grafton, GL, Stokes L, Toellner KM, Gordon J (2003) A non-voltage-gated 
calcium channel with L-type characteristics activated by B cell receptor ligation.       
Biochem. Pharmacol. 66, 2001–2009. 
 
66. Kotturi MF, Carlow DA, Lee JC, Ziltener HJ, Jefferies WA (2003) Identification 
and functional characterization of voltage-dependent calcium channels in T 
lymphocytes. J. Biol. Chem. 278, 46949–46960. 
 
67. Latour I, Louw DF, Beedle AM, Hamid J, Zamponi GW (2004) Expression of T-








68. Lu F, Chen H, Zhou C, Liu S, Guo M, Chen P, Zhuang H, Xie D, Wu S (2008)T-
type Ca
2+
 channel expression in human esophageal carcinomas: a functional role 
in proliferation. Cell Calcium 43: 49-58 
 
69. Mariot P, Vanoverberghe K, Lalevee N, Rossier MF, Prevarskaya N (2002) 
Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during 
neuroendocrine differentiation of human prostate cancer cells. J Biol. Chem. 
277:10824–1083 
 
70. CF Chen, MJ Corbley, TM Roberts, P Hess (1988) Voltage-sensitive calcium 
channels in normal and transformed 3T3 fibroblasts, Science 239 1024–1026. 
 
71. JM Caffrey, AM Brown, MD Schneider (1987) Mitogens and oncogenes can 
block the induction of specific voltage-gated ion channels, Science 236 570–573. 
 
72. MW Strobeck, M Okuda, H Schwartz, K Fukasawa (1999) Morphological 
transformation induced by activation of the mitogen-activated protein kinase 
pathway requires suppression of the T-type Ca
2+
 channel, J. Biol. Chem. 274  
15694 –15700. 
 
73. T Ueki, M Toyota, T Sohn, CJ Yeo, JP Issa, RH Hruban, M Goggins (2000) 
Hypermethylation of multiple genes in pancreatic adenocarcinoma, Cancer Res. 
60  1835–1839. 
 
74. L Shen, N Ahuja, Y Shen, NA Habib, M Toyota, A Rashid, JP Issa (2002) DNA 
methylation and environmental exposures in human hepatocellular carcinoma, J. 
Natl. Cancer Inst. 94 755–761. 
 
75. Toyota M, Ho C, Ohe-Toyota M, Baylin SB, Issa JP (1999) Inactivation of 
CACNA1G, a T-type calcium channel gene by aberrant methylation of its 5' CpG 








76. Taylor JT, Huang L, Pottle JE, Liu K, Yang Y, Zeng X, Keyser BM, Agrawal 
KC, Hansen JB, Li M (2008) Selective blockade of T-type Ca
2+
 channels 
suppresses human breast cancer cell proliferation. Cancer Lett 267: 116-124 
 
77. Gray LS, Perez-Reyes E, Gomora JC, Haverstick DM, Shattock M, McLatchie L, 
Harper J, Brooks G, Heady T, Macdonald TL (2004) The role of voltage gated T-
type Ca
2+ 
channel isoforms in mediating "capacitative" Ca
2+
 entry in cancer cells. 
Cell Calcium 36: 489-497 
 
78. Leuranguer V, Bourinet E, Lory P, Nargeot J (1998) Antisense depletion of beta-
subunits fails to affect T-type calcium channels properties in a neuroblastoma cell 
line. Neuropharmacology 37: 701-708 
 
79. Wyatt CN, Page KM, Berrow NS, Brice NL, Dolphin AC (1998) The effect of 
overexpression of auxiliary Ca
2+
 channel subunits on native Ca
2+
 channel 
currents in undifferentiated mammalian NG108-15 cells. J Physiol 510 (Pt 2): 
347-360 
 
80. Assandri R, Egger M, Gassmann M, Niggli E, Bauer C, Forster I, Gorlach A 
(1999) Erythropoietin modulates intracellular calcium in a human neuroblastoma 
cell line. J Physiol 516 (Pt 2): 343-352 
 
81. Hirooka K, Bertolesi GE, Juhasz AE, Haynes LW, Barnes S (2002) T-Type 
calcium channel alpha1G and alpha1H subunits in human retinoblastoma cells 
and their loss after differentiation. J Neurophysiol 88: 196-205 
 
82. Bertolesi GE, Shi C, Elbaum L, Jollimore C, Rozenberg G, Barnes S, Kelly ME 
(2002) The Ca
2+
 channel antagonists Mibefradil and Pimozide inhibit cell growth 
via different cytotoxic mechanisms. Mol Pharmacol 62: 210-219 
 
83. Wang YQ, Brooks G, Zhu CB, Yuan WZ, Li YQ, Wu XS (2002) Functional 
analysis of the human T-type calcium channel alpha 1H subunit gene in cellular 








84. Huang JB, Kindzelskii AL, Clark AJ, Petty HR (2004) Identification of channels 
promoting calcium spikes and waves in HT1080 tumor cells: their apparent roles 
in cell motility and invasion. Cancer Res 64: 2482-2489 
 
85. Harkins AB, Cahill AL, Powers JF, Tischler AS, Fox AP (2003) Expression of 
recombinant calcium channels support secretion in a mouse pheochromocytoma 
cell line. J Neurophysiol 90: 2325-2333 
 
86. Del Toro R, Levitsky KL, Lopez-Barneo J, Chiara MD (2003) Induction of T-
type calcium channel gene expression by chronic hypoxia. J Biol Chem 278: 
22316-22324 
 
87. Lesouhaitier O, Chiappe A, Rossier MF (2001) Aldosterone increases T-type 
calcium currents in human adrenocarcinoma (H295R) cells by inducing channel 
expression. Endocrinology 142: 4320-4330 
 
88. Zhuang H, Bhattacharjee A, Hu F, Zhang M, Goswami T, Wang L, Wu S, 
Berggren PO, Li M (2000) Cloning of a T-type Ca
2+
 channel isoform in insulin-
secreting cells. Diabetes 49: 59-64 
 
89. ME Williams, MS Washburn, M Hans, A Urrutia, PF Brust, P Prodanovich, MM 
Harpold, KA Stauderman (1999) Structure and functional characterization of a 
novel human low-voltage activated calcium channel, J. Neurochem. 72 791–799. 
 
90. Paz MF et al.(2003) Genetic unmasking of epigenetically silenced tumor 
suppressor genes in colon cancer cells deficient in DNA methyl transferases. 
Hum.Mol.Genet. 12, 2209–2219  
 
91. Wei Li W, Zhang SL, Wang N, Zhang B, Li M (2011) Blockade of T-Type Ca2+ 









92. Heo JH, Seo HN, Choe YJ, Kim, S, Oh CR, Kim YD, Rhim, H, Choo DJ, Kim J, 
Lee JY (2008) T-type Ca
2+
 channel blockers suppress the growth of human 
cancer cells. Bioorg Med Chem Lett 18:3899–3901. 
 
93. Mergler S, Wiedenmann B, Prada J (2003) R-Type Ca2+ channel Activity Is 
Associated with Chromogranin A Secretion in Human Neuroendocrine Tumor 
BON Cells J. Membrane Biol. 194, 177–186  
 
94. Li Y et. al. (2007) FSH stimulates ovarian cancer cell growth by action on 
growth factor variant receptor. Mol. Cell Endocrinol. 267, 26–37 
 
95. Graus F, Lang B, Pozo-Rosich P et. al. (2002) P/Q type calcium channel 
antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 
59:764-766 
 
96. Monstad SE, Drivsholm L, Storstein A, Aarseth JH, Haugen M, Lang B, Vincent 
B, Vedeler CA (2002) Voltage-Gated Calcium Channel (VGCC) Antibodies 
Related to the Prognosis of Small-Cell Lung Cancer; Journal of clinical oncology 
22 
 
97. Chuang RS, Jaffe H, Cribbs L, Perez-Reyes E, Swartz KJ (1998) Inhibition of T-
type voltage-gated calcium channels by a new scorpion toxin. Nat Neurosci 
1:668–674. 
 
98. SS Sidach, IM Mintz (2002) Kurtoxin, a gating modifier of neuronal high- and 
low threshold ca channels, J. Neurosci. 22 2023–2034. 
 
99. Utako Yokohama et.al. (2006) (Multiple transcripts of Ca2+ channel α1-subunits 
and a novel spliced variant of the α1C-subunit in rat ductus arteriosus Am J 
Physiol Heart Circ Physiol 290: H1660–H1670 
 
100. Mishra SK and Hermsmeyer K (1994) Selective inhibition of T-type Ca2+ 








101. Lacinova´ L, Klugbauer N, and Hofmann F (2000) Regulation of the calcium 
channel α (1G) subunit by divalent cations and organic blockers. 
Neuropharmacology 39:1254–1266. 
 
102. Mullins ME, Horowitz BZ, Linden DH, Smith GW, Norton RL, and Stump J 
(1998) Life-threatening interaction of Mibefradil and beta-blockers with 





104. P. Lijnen, R. Fagard, V. Petrov (1999) Mibefradil induced inhibition of 
proliferation of human peripheral blood mononuclear cells, J. Cardiovasc. 
Pharmacol.  33 595–604. 
 
105. R Schmitt, JP Clozel, N Iberg, FR Buhler (1995) Mibefradil prevents neointima 
formation after vascular injury in rats. Possible role of the blockade of the T-type 
voltage-operated calcium channel, Arterioscler. Thromb. Vasc. Biol. 15 1161–
1165. 
 
106. JA Chemin, A Monteil, S Dubel, J Nargeot, P Lory (2001) The α1I T-type 
calcium channel exhibits faster gating properties when overexpressed in 
neuroblastoma/glioma NG 108–115, Eur. J. Neurosci.14 1678–1686 
 
107. Taylor JT, Rider B, Huang L, Keyser B, Agrawal K, Li M (2004) A selective T-
type calcium channel antagonist inhibits breast cancer cell growth (abstract). 
FASEB A996 
 
108. Galizzi JP, Fosset M, Romey G, Laduron P, and Lazdunski M (1986) 
Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel 








109. Enyeart JJ, Biagi BA, Day RN, Sheu SS, and Maurer RA (1990) Blockade of low 
and high threshold channels by diphenylbutylpiperidine antipsychotics linked to 
inhibition of prolactin gene expression. J Biol Chem 265:16373–16379 
 
110. Armoult CVM and Florman HM (1998) Pharmacological properties of the T-type 
Ca
2+ 
current of mouse spermatogenic cells. Mol Pharmacol 53:1104–1111 
 
111. JS Strobl, Z Melkoumian, VA Peterson, H Hylton (1998) The cell death response 
to gamma-radiation in MCR-7 cells is enhanced by a neuroleptic drug, Pimozide, 
Breast Cancer Res. Treat. 51 83–95 
 
112. GL Lee, WN Hait (1985) Inhibition of growth of C6 astrocytoma cells by 
inhibition of calmodulin, Life Sci. 36 (1985) 347–354 
 
113. Neifeld JP, Tormey DC, Baker MA, Meyskens FL Jr, Taub RN (1983) Phase II 
trial of the dopaminergic inhibitor Pimozide in previously treated melanoma 
patients. Cancer Treat Rep.67(2):155-7 
 
114. WF McCalmont, TN Heady, JR Patterson, MA Lindenmuth ,DM Haverstick, L S 
Gray, TL Macdonald (2004) Design, synthesis and biological evaluation of novel 
T-type calcium channel antagonists, Bioorg. Med. Chem. Lett. 14 3691–3695 
 
115. C Armoult, J Lemos, H Florman (1997) Voltage-dependent modulation of T-type 
calcium channels by protein tyrosine phosphorylation, EMBO J. 16 1593–1599 
 
116. R Scott, J Wootton, D Dolphin (1990) Modulation of neuronal T-type calcium 
channel currents by photoactivation of intracellular guanosine 5´-O (3-thio) 
triphosphate, Neuroscience 38 285–294 
 
117. K Talavera, M Staes, A Janssens, G Droogmans, B Nilius (2004) Mechanism of 
arachidonic acid modulation of the T-type Ca
2+
 channel α1G, J. Gen. Physiol. 







118. Z Wang, M Estacion, LJ Mordan (1993) Ca2+ influx via T-type channel 
modulates PDGF-induced replication of mouse fibroblasts, Am. J.Physiol. 265 
C1239–C1246. 
 
119. Jensen RL, Wurster RD (2001) Calcium channel antagonists inhibit growth of 
subcutaneous xenograft meningiomas in nude mice. Surg. Neurol. 55, 275–283 
 
120.  Yoshida J, Ishibashi T, Nishio M (2003) Antiproliferative effect of Ca2+ channel 
blockers on human epidermoid carcinoma A431 cells. European Journal of 
Pharmacology 472, 23–31, 2003 
 
121. Yoshida J, Ishibashi T, Nishio M (2004) Antitumor effects of amlodipine, a Ca2+ 
channel blocker, on human epidermoid carcinoma A431 cells in vitro and in 
vivo. European Journal of Pharmacology 492, 103–112, 2004 
 
122. Yoshida J, Ishibashi T, Nishio M (2007) G1 cell cycle arrest by amlodipine, a 
dihydropyridine Ca
2+
 channel blocker, in human epidermoid carcinoma A431 
cells. Biochemical Pharmacology 73, 943–953 
 
123. Lee YS, Sayeed MM, Wurster RD (1994) Inhibition of cell growth and 
intracellular Ca
2+
 mobilization in human brain tumor cells by Ca
2+
 channel 
antagonists. Mol. Chem. Neuropathol. 22, 81–95. 
 
124. Taylor JM, Simpson RU (1992) Inhibition of cancer cell growth by calcium 
channel antagonists in the athymic mouse. Cancer Res. 52, 2413– 2418 
 
125. Green DR (2005) Apoptotic pathways: ten minutes to dead. Cell; 121:671–4 
 
126.  Degterev A, Yuan J (2008) Expansion and evolution of cell death programmes. 
Nat Rev Mol Cell Biol 2008; 9:378–90 
 









128. Jensen, RL, Peter M, Wurster RD (2000) Calcium channel antagonist effect on in 
vitro meningioma signal transduction pathways after growth factor stimulation. 
Neurosurgery 46,692– 702 
 
129. R Rizzuto, M Brini, M Murgia, T Pozzan (1993) Microdomains with high Ca2+ 
close to IP3-sensitive channels that are sensed by neighbouring mitochondria 
Science 262(5134):744-7 
 
130. Arnaudeau S, Kelley WL, Walsh JV Jr, Demaurex N (2001) Mitochondria 
recycle Ca
2+
 to the endoplasmic reticulum and prevent the depletion of 
neighbouring endoplasmic reticulum regions. 276(31):29430-9 
 
131. G Hajnoczky, LD Robb-Gaspers, LD Seitz, AP Thomas (1995) Decoding of 
cytosolic calcium oscillations in the mitochondria Cell 82(3):415-24 
 
132. G Hajnoczky, G Csordas, M Yi (2002) Old players in a new role: mitochondria-
associated membranes, VDAC, and ryanodine receptors as contributors to 
calcium signal propagation from endoplasmic reticulum to the mitochondria. Cell 
Calcium 32(5-6):363-77 
 
133. P Pacher, G Hajnoczky (2001) Propagation of the apoptotic signal by 
mitochondrial waves. EMBO J. 20(15):4107-21 
 
134. Oyadomari S, Mori M (2004) Roles of CHOP/GADD153 in endoplasmic 
reticulum stress Cell Death Differ 11,381-389 
 
135. DG Breckenridge, M Germain, JP Mathai, M Nguyen, GC Shore (2003) 
Regulation of apoptosis by endoplasmic reticulum pathways, Oncogene 22 8608–
8618. 
 
136. R Rizzuto, P Pinton, M Chami, G Szabadkai, PJ Magalhaes, F Di Virgilio, T 









137. RV Rao, HM Ellerby, DE Bredesen (2004) Coupling endoplasmic reticulum to 
the cell death program, Cell Death Diff. 11 372–380. 
 
138. Kaufman RJ (1999) Stress signaling from the lumen of the endoplasmic 
reticulum: coordination of gene transcriptional and translational controls. Genes 
Dev13: 1211–1233 
 
139. Rao RV, Hermel E, Castro-Obregon S, Del Rio G, Ellerby LM, Ellerby HM and 
Bredesen DE (2001) Coupling endoplasmic reticulum stress to the cell death 
program. Mechanism of caspase activation. J. Biol. Chem. 276: 33869–33874 
 
140. Liu H, Bowes III RC, van de Water B, Sillence C, Nagelkerke JF and Stevens JL 
(1997) Endoplasmic reticulum chaperones GRP78 and calreticulin prevent 
oxidative stress, Ca
2+
 disturbances, and cell death in renal epithelial cells. J.Biol. 
Chem. 272: 21751–21759 
 
141. Rao R, Poksay K, Castro-Obregon S, Schiilling B, Row RH, dcl Rio G, Gibson 
BW, Ellerby HM and Bredesen DE (2004) Molecular components of a cell death 
pathway activated by endoplasmic reticulum stress. J. Biol. Chem. 279:177–187 
 
142.  Peter Hersey, Xu Dong Zhang (2008) Adaptation to ER stress as a driver of 
malignancy and resistance to therapy in human melanoma. Pigment Cell 
Melanoma Res. 21; 358–367 
 
143. Yorimitsu T, Nair U, Yang Z, Klionsky DJ (2006) Endoplasmic reticulum stress 
triggers autophagy Biol. Chem. 281: 30299–30304. 
 
144. Høyer-Hansen M, Bastholm L, Szyniarowski P, Campanella M, Szabadkai G, 
Farkas T et. al. (2007) Control of macroautophagy by calcium, calmodulin-
dependent kinase kinase-b and Bcl-2. Mol Cell 25: 193–205. 
 
145. Kouroku Y, Tanida I, Ueno T, Isoai A, Kumagai H et. al. (2007) ER stress 







conversion, an essential step for autophagy formation. Cell Death Differ14: 230–
239. 
 
146. M Høyer-Hansen, M Jaattela (2007) Connecting endoplasmic reticulum stress to 
autophagy by unfolded protein response and calcium. Cell Death Differ 14, 
1576–1582  
 
147. Kroemer G, Mariño G, Levine B (2010) Autophagy and the Integrated Stress 
Response. Mol. Cell 40; 280-293. 
 
148. Mijaljica D, Prescott M, Devenish RJ (2011) Microautophagy in mammalian 
cells: revisiting a 40-year-old conundrum. Autophagy.7(7):673-82. 
 
149. Arias E, Cuervo AM (2011) Chaperone-mediated autophagy in protein quality 
control. Curr Opin Cell Biol.23(2):184-9 
 
150. Levine B, Klionsky DJ (2004) Development by self-digestion: molecular 
mechanisms and biological functions of autophagy. Dev Cell 6: 463–477. 
 
151. Kroemer G, Jaattela (2005) M. Lysosomes and autophagy in cell death control. 
Nat Rev Cancer 5: 886–897. 
 
152. Codogno P, Meijer AJ (2005) Autophagy and signaling: their role in cell survival 
and cell death. Cell Death Differ12 (Suppl 2): 1509–1518. 
 
153. Sabatini DM (2006) mTOR and cancer: insights into a complex relationship. Nat 
Rev Cancer 6: 729–734 
 
154. Fader CM, Sanchez D, Furlan M and Colombo MI (2008) Induction of 
autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in 
k562 cells. Traffic 9, 230–250. 
 
155. Hay JC (2007) Calcium: a fundamental regulator of intracellular membrane 







156. Decuypere JP, Bultynck G, Parys JB (2011) A dual role for Ca2+ in autophagy 
regulation Cell Calcium.50(3):242-50 
 
157. Demarchi F, Bertoli C, Copetti T, Tanida I, Brancolini C et.al. (2006) Calpain is 
required for macroautophagy in mammalian cells. J Cell Biol175: 595–605. 
 
158. Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L et. al. 
(2006) Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat 
Cell Biol 8:1124–1132 
 
159. Handerson T, Pawelek, J. (2003) β1, 6-branched oligosaccharides and coarse 
vesicles: a common and pervasive phenotype in melanoma and other human 
cancers. Cancer Res ; 63: 5363. 
 
160. Handerson T, Berger A, Harigopol M, et. al. (2007) Melanophages reside in 
hypermelanotic aberrantly glycosylated tumor areas and predict improved 
outcome in primary CMM. J Cutan Pathol ; 34: 667. 
 
161. Jensen, RL, Origitano TC, Lee YS, Weber M, Wurster RD (1995) In vitro growth 
inhibition of growth factor-stimulated meningioma cells by calcium channel 
antagonists. Neurosurgery 36, 365– 373. 
 
162. Mizushima N (2010) The role of the Atg1/ULK1 complex in autophagy 
regulation. Current Opinion in Cell Biology 22:132–139 
 
163. Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S et. al. (2006) 
Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol. 
Cell Biol. 26: 9220–9231. 
 
164. Moscat J and Diaz-Meco MT (2009) P62 at the crossroads of autophagy, 
apoptosis, and cancer. Cell 137, 1001–1004. 
 
165. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H 







autophagy and has a protective effect on huntingtin-induced cell death. J. Cell 
Biol. 171, 603–614. 
 
166. Pankiv S. et al. (2007) P62/SQSTM1 binds directly to Atg8/LC3 to facilitate 
degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 
282, 24131–24145. 
 
167. Ichimura Y. et al. (2008) Structural basis for sorting mechanism of p62 in 
selective autophagy. J. Biol. Chem. 283, 22847–22857. 
 
168. Yue Z, Jin S, Yang C, Levine AJ, Heintz N (2003) Beclin 1, an autophagy gene 
essential for early embryonic development, is a haploinsufficient tumor 
suppressor. Proc Natl Acad Sci U S A100:15077–82. 
 
169. Qu X, Yu J, Bhagat G, et.al. (2003) Promotion of tumorigenesis by heterozygous 
disruption of the Beclin 1 autophagy gene. J Clin Invest; 112:1809–20. 
 
170. Kondo Y, Kanzawa T, Sawaya R, Kondo S. (2005) The role of autophagy in 
cancer development and response to therapy. Nat Rev Cancer ; 5:726–34. 
 
171. Feng Z, Zhang H, Levine AJ, Jin S.(2005) The coordinate regulation of the p53 
and mTOR pathways in cells. Proc Natl Acad Sci U S A ; 102 : 8204–9. 
 
172. Arico S, Petiot A, Bauvy C et al. (2001) The tumor suppressor PTEN positively 
regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein 
kinase B pathway. J Biol Chem 276:35243–6. 
 
173. Boya P, Gonzalez-Polo RA, Casares N et. al. (2005) Inhibition of macroauto- 
phagy triggers apoptosis. Mol Cell Biol 25:1025–40. 
 
174. Lum JJ, Bauer DE, Kong M et. al. (2005) Growth factor regulation of autophagy 








175. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and 
selfkilling: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 
8:741–52. 
 
176.  White E, DiPaola RS (2009) The double-edged sword of autophagy modulation 
in cancer. Clin Cancer Res; 15:5308–16. 
 
177. Miracco C, Cevenini G, Franchi A et.al. (2010) Beclin 1 and LC3 autophagic 
gene expression in cutaneous melanocytic lesions Hum Pathol.41(4):503-12 
 
178. Lazova R, Pawelek J. (2009) Why do melanomas get so dark? Exp Dermatol; in 
press. 
 
179. Lazova R, Klump V, Pawelek J (2010) Autophagy in cutaneous malignant 
melanoma. J Cutan Pathol.37(2):256-68 
 
180. Ma X, H Piao S, Wang D et.al (2011) Measurements of tumor cell autophagy 
predicts invasiveness, resistance to chemotherapy, and survival in melanoma. 
Clin Cancer Res;17:3478-89 
 
181. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G et. al. 
(2006) Autophagy promotes tumor cell survival and restricts necrosis, 
inflammation, and tumorigenesis. Cancer Cell; 10:51–64. 
 
182. Han J, Hou W, Goldstein L A, Lu C, Stolz D B, Yin X M et. al. (2008) 
Involvement of protective autophagy in TRAIL resistance of apoptosis-defective 
tumor cells. J Biol Chem; 283:19665–77. 
 
183. Shacka JJ, Klocke BJ, Roth KA (2006) Autophagy, bafilomycin and cell death: 
the "a-B-cs" of plecomacrolide-induced neuroprotection.Autophagy 2:228–30. 
 
184. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan G et. al. (2007) 
Autophagy inhibition enhances therapy-induced apoptosis in a Mycinduced 







185. Li J, Hou N, Faried A, Tsutsumi S, Kuwano H (2010) Inhibition of autophagy 
augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in 
vivo model. Eur J Cancer 46:1900–9. 
 
186. Carew JS, Medina EC, Esquivel JA 2nd, Mahalingam D, Swords R, Kelly K et 
al. (2010) Autophagy inhibition enhances vorinostat-induced apoptosis via 
ubiquitinated protein accumulation. J Cell Mol Med 14:2448–59. 
 
187. Wu Z, Chang PC, Yang JC, Chu CY, Wang LY, Chen NT, et. al. (2010) 
Autophagy blockade sensitizes prostate cancer cells towards Src family kinase 
inhibitors. Genes Cancer ; 1:40–9. 
 
188. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA (2010) 
Clinical efficacy and side effects of antimalarials in systemic lupus 
erythematosus: a systematic review. Ann Rheum Dis 69:20–8. 
 
189. Rosenfeld MR, Grossman SA, Brem S, Mikkelsen T, Wang D, Piao S et. al. 
(2010) Pharmacokinetic analysis and pharmacodynamic evidence of autophagy 
inhibition in patients with newly diagnosed glioblastoma treated on a phase I trial 
of hydroxychloroquine in combination with adjuvant temozolomide and radiation 
(ABTC 0603). J Clin Oncol 28:15s. 
 
190. Ding WX, Ni HM, Gao W, Chen X, Kang JH, Stolz DB, et. al. (2009) Oncogenic 
transformation confers a selective susceptibility to the combined suppression of 
the proteasome and autophagy. Mol. Cancer Ther. 8:2036–45. 
 
191. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima 
R, Yokoyama M, Mishima K, Saito I, Okano H, Mizushima N (2006) 
Suppression of basal autophagy in neural cells causes neurodegenerative disease 
in mice. Nature 15 ; 441 (7095):885-9. 
 
192. Komatsu M et. al. (2006) Loss of autophagy in the central nervous system causes 







193. Pua HH, Dzhagalov I, Chuck M, Mizushima N & He YW (2007) A critical role 
for the autophagy gene Atg5 in T cell survival and proliferation. J. Exp. Med. 
204, 25–31  
 
194. Takacs-Vellai K. et. al. (2005) Inactivation of the autophagy gene bec-1 triggers 
apoptotic cell death in C. elegans. Curr. Biol. 15, 1513–1517. 
 
195. Ganley IG, Wong PM, Gammoh N, Jiang X (2011) Distinct autophagosomal-
lysosomal fusion mechanism revealed by Thapsigargin-induced autophagy arrest. 
Mol Cell. 42(6):731-43. 
 
196. Katayama M, Kawaguchi T, Berger MS, Pieper RO (2007) DNA damaging 
agent-induced autophagy produces a cytoprotective adenosine triphosphate surge 
in malignant glioma cells. Cell Death Differ 2007; 14:548–58. 
 
197. Carew JS, Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L et al. (2007) 
Targeting autophagy augments the anticancer activity of the histone deacetylase 
inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 110:313–
22. 
 
198. Gonzalez-Polo RA. et al. (2005) The apoptosis/autophagy paradox: autophagic 
vacuolization before apoptotic death. J. Cell Sci. 118, 3091–3102 (2005). 
 
199. Kroemer G, Galluzzi L, Brenner C (2007) Mitochondrial membrane permeabili- 
zation in cell death. Physiol.Rev. 87, 99–163. 
 
200. Rubinsztein DC, Gestwicki JE, Murphy, LO & Klionsky DJ (2007) Potential 
therapeutic applications of autophagy. Nature Rev. Drug Discov.6, 304–312. 
 
201. Zhineng J. Yang, Cheng E. Chee, Shengbing Huang et. al. (2011) The Role of 








202.  Sorolla, A, Yeramian A, Dolcet X et. al. (2008) Effect of proteasome inhibitors 
on proliferation and apoptosis of human cutaneous melanoma-derived cell lines. 
Br. J. Dermatol. 158, 4 96–504. 
 
203. Jacob R (1990) Agonist-stimulated divalent cation entry into single cultured 
human umbilical vein endothelial cells. J. Physiol. (Lond.) 421, 55–77. 
 
204. Kaku U, Lee TS, Arita M, Hadama T, Ono K (2003) The gating and conductance 
properties of Cav3.2 low-voltage-activated T-type calcium channels. Jpn. J. 
Physiol. 53, 165–172. 
 
205. Jiang CC, Chen LH, Gillespie S, Wang YF, Kiejda KA, Zhang XD, Hersey P 
(2007) Inhibition of MEK sensitizes human melanoma cells to endoplasmic 
reticulum stress-induced apoptosis. Cancer Res 67:9750–9761. 
 
206. Nakamura M, Gotoh T, Okuno Y, Tatetsu H, Sonoki T, Uneda S, Mori M, 
Mitsuya H, Hata H (2006) Activation of the endoplasmic reticulum stress 
pathway is associated with survival of myeloma cells. Leuk Lymphoma 47:531–
539. 
 
207. Loechner KJ, Salmon WC, Fu J, Patel S and McLaughlin JT (2009) Cell cycle-
dependent localization of voltage-dependent calcium channels and the mitotic 
apparatus in a neuroendocrine cell line (AtT-20). Int. J. Cell Biol. 487959, 1–12. 
 
208. Silver DL, Pavan WJ (2006) The origin and development of neural crest-derived 
melanocytes. In Melanocytes to Melanoma, Vol. I, V.J. Hearing, and S.P. Leong, 
eds. (Totowa, NJ: Humana Press), pp. 3–26. 
 
209. Evans RM, Zamponi GW (2006) Presynaptic calcium channels integration  
centres  for neuronal signaling pathways. Trends Neurosci. 29, 617–624. 
 
210. Bedogni B, Powell MB (2006) Skin hypoxia: a promoting environmental factor 








211. Pluteanu F, Cribbs LL (2009) T-type calcium channels are regulated by 
hypoxia/reoxygenation in ventricular myocytes. Am. J. Physiol. Heart Circ. 
Physiol. 297, H1304–h1313. 
 
212. Wang G, Yang ZQ, Zhang K (2010) Endoplasmic reticulum stress response in 
cancer: molecular mechanism and therapeutic potential. Am J Transl Res.1;2 (1) : 
65-74. 
 
213. Rossier MF (2006) T channels and steroid biosynthesis: in search of a link with 
mitochondria. Cell Calcium 40 (2):155-64. 
 
214. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami 
E, Ohsumi Y, Yoshimori T (2000) LC3, a mammalian homologue of yeast 
Apg8p, is localized in autophagosome membranes after processing. EMBO J. 1; 
19 (21) : 5720-8. 
 
215. Mizushima N, Yoshimori T (2007) How to interpret LC3 immunoblotting. 
Autophagy 3:542-5. 
 
216. Koschak A, Reimer D, Huber I, Grabner M, Glossmann H, Engel J, Striessnig J 
(2001) α1D (Cav1.3) subunits can form L-type calcium channels activating at 
negative voltages. J. Biol. Chem. 276, 22100–22106. 
 
217.  Lipscombe D, Helton TD and Xu W (2004) L-type calcium channels: the low 
down. J. Neurophysiol. 92, 2633–2641. 
 
218. Triggle DJ (2003) 1,4-Dihydropyridines as calcium channel ligands and 
privileged structures. Cell. Mol. Neurobiol. 23, 293–303. 
 









220. Marcantoni A, Baldelli P, Hernandez-Guijo JM, Comunanza V, Carabelli V and 
Carbone E (2007) L-type Ca
2+
 channels in adrenal chromaffin cells: role in pace-
making and secretion. Cell Calcium 42, 397–408. 
 
221. Eyden B, Pandit D and Banerjee SS (2005) Malignant melanoma with 
neuroendocrine differentiation: clinical, histological, immunohistochemical and 
ultrastructural features of three cases. Histopathology 47, 402–409. 
 
222. Taylor JT, Zeng XB, Pottle JE, Lee K, Wang AR, Yi SG, Scruggs JA, Sikka SS 
and Li M (2008) Ca
2+
 signaling and T-type calcium channels in cancer cell 
cycling. World J. Gastroenterol. 14, 4984–4991. 
 
223. Panner A, Wurster RD (2006) T-type calcium channels and tumour proliferation. 
Cell Calcium 40, 253–259. 
 
224.  Williams A, Sarkar S, Cuddon P et al. (2008) Novel targets for Huntington’s 
disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 4, 295–
305. 
 
225. Kahl CR, Means AR (2003) Regulation of cell cycle progression by 
calcium/calmodulin-dependent pathways. Endocr. Rev. 24, 719–736. 
 
226. Brewer JW, Hendershot LM, Sherr CJ, Diehl JA (1999) Mammalian unfolded 
protein response inhibits Cyclin D1 translation and cell-cycle progression. Proc 
Natl Acad Sci U S A. 96(15):8505-10. 
 
227. Kwong L, Chin L, Wagner SN (2007) Growth factors and oncogenes as targets in 
melanoma: lost in translation? Adv. Dermatol. 23, 99–129. 
 
228. Mayorga ME, Sanchis D, Perez de Santos AM et. al. (2006) Antiproliferative 
effect of STI571 on cultured human cutaneous melanoma-derived cell lines. 








229. Yeramian A, Sorolla A, Velasco A et. al. (2011) Inhibition of activated receptor 
tyrosine kinases by Sunitinib induces growth arrest and sensitises melanoma cells 
to Bortezomib by blocking Akt pathway. Int. J. Cancer 130, 967–978. 
 
230. Martinez-Alonso M, Llecha N, Mayorga ME et. al. (2009) Expression of 
somatostatin receptors in human melanoma cell lines: effect of two different 
somatostatin analogues, octreotide and SOM230, on cell proliferation. J. Int. 
Med. Res. 37, 1813–1822. 
 
231. Nilius B, Prenen J, Kamouchi M, Viana F, Voets T, and Droogmans G (1997) 
Inhibition by Mibefradil, a novel calcium channel antagonist, of Ca
2+
 and volume 
activated Chloride channels in macrovascular endothelial cells. Br J Pharmacol 
121:547–555. 
 
232. Moretti L, Cha YI, Lu B (2007) Switch between apoptosis and autophagy: 
radiation- induced endoplasmic reticulum stress? Cell Cycle; 6: 793-8. 
 
233. Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D, Kaufman RJ, 
Ma D, Coen DM, Ron D, Yuan J (2005) A selective inhibitor of eIF2α 
dephosphorylation protects cells from ER stress. Science ; 307:935-9. 
 
234. Martin RL, Lee JH, Cribbs LL, Perez-Reyes E, Hanck DA (2000) Mibefradil 
block of cloned T-type calcium channels. J Pharmacol Exp Ther.; 295(1):302-8. 
 
235.  Santi CM, Cayabyab FS, Sutton KG, McRory JE, Mezeyova J, Hamming KS, 
Parker D, Stea A, Snutch TP (2002) Differential inhibition of T-type calcium 
channels by neuroleptics. J Neurosci. 15; 22(2):396-403. 
 
236. Liu JH, Bijlenga P, Occhiodoro T, Fischer-Lougheed J, Bader CR, Bernheim L. 




 currents in human 
fusion-competent  myoblast. Br J Pharmacol; 126(1): 245-50. 
 
237. McNulty MM, Hanck DA (2004) State-dependent Mibefradil block of Na+ 








238. Keilholz U, Suciu S, Bedikian AY, Punt, CJ, Gore M, Kruit W, Pavlick AC., 
Spatz A, Gilles E, Eggermont AM (2007) LDH is a prognostic factor in stage IV 
melanoma patients (pts) but is a predictive factor only for bcl2 antisense 
treatment efficacy: Re-analysis of GM301 and EORTC18951 randomized trials. 
American Society of Clinical Oncology Meeting, Abstract 8552, 485s. 
 
239. Rutkowski DT, Kaufman RJ (2007) That which does not kill me makes me 
stronger: adapting to chronic ER stress. Trends Biochem Sci. 32(10):469-76. 
 
240. Li X, Zhang K, Li Z (2011) Unfolded protein response in cancer: the physician's 
perspective. J Hematol Oncol. Feb 23;4:8 
 
241. Scheuner D, Song B, McEwen E, Liu C, Laybutt R, Gillespie P, Saunders T, 
Bonner-Weir S and Kaufman RJ (2001) Translational control is required for the 
unfolded protein response and in vivo glucose homeostasis. Mol. Cell 7:1165–
1176. 
 
242. Harding HP, Novoa II, Zhang Y, Zeng H, Wek R, Schapira M, Ron D (2000) 
Regulated translation initiation controls stress-induced gene expression in 
mammalian cells. Mol. Cell 6: 1099–1108. 
 
243. Okada T, Yoshida H, Akazawa R, Negishi M and Mori K (2002) Distinct roles of 
activating transcription factor 6 (ATF6) and double-stranded RNA-activated 
protein kinase-like endoplasmic reticulum kinase (PERK) in transcription during 
the mammalian unfolded protein response. Biochem. J. 366: 585–594 2007 
 
244. Klionsky DJ, Cuervo AM, Seglen PO (2007) Methods for monitoring autophagy 
from yeast to human. Autophagy 3(3):181-206 
 
245. Brinda Ravikumar, Sovan Sarkar, Janet E. Davies et.al. (2010) Regulation of 









246. Noboru Mizushima and Daniel J. Klionsky (2007) Protein Turnover Via 
Autophagy: Implications for Metabolism Annual Review of Nutrition ; 27:19-40. 
 
247. Robin Mathew, Vassiliki Karantza-Wadsworth and Eileen White (2007) Role of 
autophagy in cancer Nat. Rev. Cancer 7; 961-967 
 
248. Calfon M, Harding HP (2004) Marcie Calfon’s & Heather Harding’s protocol for 
detection of XBP-1 processing in mouse or human cells (http://saturn. 
med.nyu.edu /research/mp/ronlab/protocols/XBP-1.splicing.04.09.16.pdf ). 
 
249. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP, Clark SG, Ron D 
(2002) IRE1 couples endoplasmic reticulum load to secretory capacity by 
processing the XBP-1 mRNA. Nature 415: 92–96 
 
 
 
 
 
 
 
 
